2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Saved in:

Bibliographic Details
Published in	Europace (London, England) Vol. 23; no. 10; pp. 1612 - 1676
Main Authors	Steffel, Jan, Collins, Ronan, Antz, Matthias, Cornu, Pieter, Desteghe, Lien, Haeusler, Karl Georg, Oldgren, Jonas, Reinecke, Holger, Roldan-Schilling, Vanessa, Rowell, Nigel, Sinnaeve, Peter, Vanassche, Thomas, Potpara, Tatjana, Camm, A John, Heidbüchel, Hein
Format	Journal Article
Language	English
Published	England Oxford University Press 09.10.2021
Subjects	Administration, Oral Anticoagulants - adverse effects apixaban Atrial Fibrillation - complications Atrial Fibrillation - diagnosis Atrial Fibrillation - drug therapy dabigatran Dabigatran - therapeutic use DOACs edoxaban EHRA Practical Guide Humans NOACs Official Statement Pyridones - therapeutic use rivaroxaban Rivaroxaban - therapeutic use Stroke - diagnosis Stroke - etiology Stroke - prevention & control NOACs dabigatran rivaroxaban DOACs apixaban edoxaban
Online Access	Get full text
ISSN	1099-5129 1532-2092 1532-2092
DOI	10.1093/europace/euab065

Cover

Author	Cornu, Pieter Oldgren, Jonas Camm, A John Sinnaeve, Peter Desteghe, Lien Roldan-Schilling, Vanessa Vanassche, Thomas Antz, Matthias Heidbüchel, Hein Steffel, Jan Collins, Ronan Haeusler, Karl Georg Rowell, Nigel Potpara, Tatjana Reinecke, Holger
Author_xml	– sequence: 1 givenname: Jan surname: Steffel fullname: Steffel, Jan email: j.steffel@gmx.ch organization: Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich, Switzerland – sequence: 2 givenname: Ronan surname: Collins fullname: Collins, Ronan organization: Age-Related Health Care, Tallaght University Hospital / Department of Gerontology Trinity College, Dublin, Ireland – sequence: 3 givenname: Matthias surname: Antz fullname: Antz, Matthias organization: Department of Electrophysiology, Hospital Braunschweig, Braunschweig, Germany – sequence: 4 givenname: Pieter surname: Cornu fullname: Cornu, Pieter organization: Faculty of Medicine and Pharmacy, Research Group Clinical Pharmacology and Clinical Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium – sequence: 5 givenname: Lien surname: Desteghe fullname: Desteghe, Lien organization: Cardiology, Antwerp University and University Hospital, Antwerp, Belgium – sequence: 6 givenname: Karl Georg surname: Haeusler fullname: Haeusler, Karl Georg organization: Department of Neurology, Universitätsklinikum Würzburg, Würzburg, Germany – sequence: 7 givenname: Jonas surname: Oldgren fullname: Oldgren, Jonas organization: Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden – sequence: 8 givenname: Holger surname: Reinecke fullname: Reinecke, Holger organization: Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Münster, Münster, Germany – sequence: 9 givenname: Vanessa surname: Roldan-Schilling fullname: Roldan-Schilling, Vanessa organization: University of Murcia, Murcia, Spain – sequence: 10 givenname: Nigel surname: Rowell fullname: Rowell, Nigel organization: Middlesbrough, UK – sequence: 11 givenname: Peter surname: Sinnaeve fullname: Sinnaeve, Peter organization: Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium – sequence: 12 givenname: Thomas surname: Vanassche fullname: Vanassche, Thomas organization: Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium – sequence: 13 givenname: Tatjana surname: Potpara fullname: Potpara, Tatjana organization: School of Medicine, Belgrade University, Belgrade, Serbia – sequence: 14 givenname: A John surname: Camm fullname: Camm, A John organization: Cardiology Clinical Academic Group, Molecular & Clinical Sciences Institute, St George’s University, London, UK – sequence: 15 givenname: Hein surname: Heidbüchel fullname: Heidbüchel, Hein organization: Cardiology, Antwerp University and University Hospital, Antwerp, Belgium
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33895845$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-459047$$DView record from Swedish Publication Index
BookMark	eNqNkUtv1DAUhS1URB-wZ4W8RKIB24mTeIWi0geiohWi3VqOx5kYZexgO4zmj_T3codMK8oCWPna9zvn6h4foj3nnUHoJSVvKRH5OzMFPyptoFAtKfkTdEB5zjJGBNuDmgiRccrEPjqM8RshpGKCP0P7eV4LXhf8AN0xwig-3foY5fCFUSHhL_0m9SvcxOi1Vcl6h6-D0slqNeDzyS4MhqfUG3wToezwZ--yW5vUyjr8CTcuqaV3NiZ8FUABd6u9Wk6DciliYK7B1GzrtU09blKwgJ3ZNthh-DXvOXraqSGaF7vzCN2cnX49ucgur84_njSXmS5EnbKWdISZmkMWC9hb1azjhWFkoRnhXVcVdUfasiUK7kLUvOTQrjkreNkpRWl-hOjsO7lRbdZqGOQY7EqFjaREbjOW9xnLXcagOZ41cW3GqX0QeGXlB3vbSB-WcppkwQUpKsDfzziwK7PQsDeE8kj1uONsL5f-h6S0zEteleDweucQ_PfJxCRXNmoDUTnjpygZp3VVEEFqQF_9Puxhyv2HA1DOgA4-xmA6qeHftpHDbDv8bWvyh_A_gnozS_w0_pv-CSJa5rM
CitedBy_id	crossref_primary_10_1007_s00228_024_03689_3 crossref_primary_10_3390_jcm10225268 crossref_primary_10_1016_j_neurot_2025_e00574 crossref_primary_10_1002_bcp_70032 crossref_primary_10_1016_j_thromres_2024_01_012 crossref_primary_10_1371_journal_pone_0295511 crossref_primary_10_1016_j_archger_2024_105602 crossref_primary_10_1111_bcp_15316 crossref_primary_10_1007_s10072_024_07937_3 crossref_primary_10_2147_IJGM_S289295 crossref_primary_10_1097_FTD_0000000000001042 crossref_primary_10_3389_fcvm_2022_1009475 crossref_primary_10_2174_0113816128293940240315073345 crossref_primary_10_1055_a_2337_4025 crossref_primary_10_1016_j_hrthm_2024_01_025 crossref_primary_10_1016_j_jacadv_2023_100813 crossref_primary_10_1177_10600280211046087 crossref_primary_10_1016_j_hrthm_2024_01_028 crossref_primary_10_1136_openhrt_2022_002197 crossref_primary_10_1016_j_thromres_2021_11_026 crossref_primary_10_1177_10760296231180865 crossref_primary_10_3389_fphar_2023_1125576 crossref_primary_10_1016_j_archger_2024_105734 crossref_primary_10_1007_s40264_024_01476_8 crossref_primary_10_1016_S1474_4422_23_00209_0 crossref_primary_10_1111_bcp_15785 crossref_primary_10_1016_j_recesp_2024_09_011 crossref_primary_10_1007_s10557_023_07499_0 crossref_primary_10_1016_j_ejim_2023_08_003 crossref_primary_10_3389_fcvm_2023_1301442 crossref_primary_10_1161_JAHA_124_036832 crossref_primary_10_1055_s_0041_1740492 crossref_primary_10_1186_s12872_025_04615_w crossref_primary_10_3390_jcm11040986 crossref_primary_10_1093_ehjqcco_qcad019 crossref_primary_10_3390_life12101594 crossref_primary_10_1161_CIRCULATIONAHA_123_066600 crossref_primary_10_1177_11297298211072407 crossref_primary_10_1007_s00784_023_05424_1 crossref_primary_10_1016_j_clinthera_2024_06_002 crossref_primary_10_1055_a_2065_1625 crossref_primary_10_1097_CM9_0000000000002906 crossref_primary_10_1080_14779072_2024_2421800 crossref_primary_10_1002_phar_2726 crossref_primary_10_1016_j_cpcardiol_2023_101738 crossref_primary_10_1136_openhrt_2024_002602 crossref_primary_10_14412_2074_2711_2021_5_4_13 crossref_primary_10_1093_ehjci_jeac106 crossref_primary_10_1007_s40266_024_01138_5 crossref_primary_10_1093_europace_euac020 crossref_primary_10_1007_s11239_021_02561_w crossref_primary_10_1016_j_amjcard_2023_08_046 crossref_primary_10_1093_ndt_gfae042 crossref_primary_10_1371_journal_pone_0279297 crossref_primary_10_1177_02841851221081474 crossref_primary_10_1002_bcp_70007 crossref_primary_10_1007_s12181_023_00633_0 crossref_primary_10_36660_abc_20240590i crossref_primary_10_3390_jcm13071891 crossref_primary_10_1186_s40246_023_00506_3 crossref_primary_10_1002_ctm2_1263 crossref_primary_10_3389_fphar_2023_1286559 crossref_primary_10_17235_reed_2022_8920_2022 crossref_primary_10_36290_vnl_2024_011 crossref_primary_10_1002_cpdd_1156 crossref_primary_10_1001_jamanetworkopen_2022_28500 crossref_primary_10_3389_fcvm_2023_1186453 crossref_primary_10_1186_s42466_022_00174_z crossref_primary_10_1016_S1636_5410_22_47167_4 crossref_primary_10_3389_fcvm_2023_1040834 crossref_primary_10_1111_bcpt_13953 crossref_primary_10_1016_j_anrea_2024_04_004 crossref_primary_10_1007_s40263_024_01071_6 crossref_primary_10_18087_cardio_2023_10_n2284 crossref_primary_10_18794_aams_158478 crossref_primary_10_1016_j_jtha_2023_06_036 crossref_primary_10_1182_bloodadvances_2024013126 crossref_primary_10_1007_s40256_023_00582_9 crossref_primary_10_1016_j_arr_2022_101761 crossref_primary_10_1093_europace_euac123 crossref_primary_10_3390_ijerph20075293 crossref_primary_10_1093_eurheartj_ehac270 crossref_primary_10_1253_circj_CJ_24_0614 crossref_primary_10_3390_jcm12062379 crossref_primary_10_1093_jalm_jfae116 crossref_primary_10_1136_openhrt_2023_002555 crossref_primary_10_1007_s12325_022_02368_y crossref_primary_10_18087_cardio_2021_12_n1872 crossref_primary_10_31083_j_rcm2307236 crossref_primary_10_1016_S1634_7358_22_47250_0 crossref_primary_10_3390_cancers15143546 crossref_primary_10_1253_circj_CJ_22_0290 crossref_primary_10_3390_ph17111431 crossref_primary_10_1007_s40256_024_00664_2 crossref_primary_10_1016_j_ejim_2023_10_010 crossref_primary_10_1016_j_hrthm_2023_05_017 crossref_primary_10_1016_j_jacasi_2022_06_004 crossref_primary_10_1177_10760296241279545 crossref_primary_10_1038_s41598_024_65237_4 crossref_primary_10_1017_S1463423623000622 crossref_primary_10_1177_10760296231200223 crossref_primary_10_1093_europace_euad226 crossref_primary_10_1111_joim_20006 crossref_primary_10_1007_s11739_022_03156_w crossref_primary_10_1007_s00108_023_01622_x crossref_primary_10_1111_echo_15759 crossref_primary_10_1007_s00228_024_03773_8 crossref_primary_10_1093_ehjopen_oead004 crossref_primary_10_1007_s12325_022_02333_9 crossref_primary_10_3389_fcvm_2022_951695 crossref_primary_10_3390_ijtm4020022 crossref_primary_10_3390_jcm11236956 crossref_primary_10_46310_tjim_1176071 crossref_primary_10_3389_fcvm_2023_1061618 crossref_primary_10_3389_fneur_2023_1330421 crossref_primary_10_17816_medjrf635877 crossref_primary_10_1186_s12933_021_01368_6 crossref_primary_10_1111_pace_14429 crossref_primary_10_3389_fcvm_2022_856222 crossref_primary_10_4330_wjc_v15_i8_375 crossref_primary_10_1007_s11239_022_02721_6 crossref_primary_10_1002_phar_2888 crossref_primary_10_1016_j_rpth_2024_102584 crossref_primary_10_3390_cancers16020450 crossref_primary_10_1002_phar_2881 crossref_primary_10_3390_jcdd10110444 crossref_primary_10_1038_s41405_023_00164_6 crossref_primary_10_1177_17539447241290429 crossref_primary_10_1016_j_rccl_2021_09_005 crossref_primary_10_1177_10760296231171081 crossref_primary_10_3389_fneur_2024_1389283 crossref_primary_10_1007_s40263_023_01052_1 crossref_primary_10_1016_j_heliyon_2023_e14456 crossref_primary_10_31083_j_rcm2303098 crossref_primary_10_23736_S1593_232X_24_00635_0 crossref_primary_10_1097_NRL_0000000000000579 crossref_primary_10_1007_s00101_022_01142_7 crossref_primary_10_2147_IPRP_S397844 crossref_primary_10_1136_openhrt_2023_002515 crossref_primary_10_1055_a_2021_8910 crossref_primary_10_1093_eurheartj_ehad123 crossref_primary_10_1002_joa3_13082 crossref_primary_10_1016_j_cpcardiol_2022_101188 crossref_primary_10_1016_j_ejim_2023_08_019 crossref_primary_10_2217_fca_2022_0044 crossref_primary_10_1016_j_rpth_2024_102575 crossref_primary_10_1111_bcp_15961 crossref_primary_10_3390_jcm13113076 crossref_primary_10_12677_ACM_2023_1361309 crossref_primary_10_1007_s00228_023_03570_9 crossref_primary_10_1093_europace_euad204 crossref_primary_10_1093_europace_euac236 crossref_primary_10_3390_biology12040491 crossref_primary_10_1016_j_ejim_2023_08_020 crossref_primary_10_3389_fphar_2025_1514801 crossref_primary_10_3390_pharmaceutics16101319 crossref_primary_10_1016_j_ijcard_2024_131894 crossref_primary_10_1016_j_rec_2022_10_010 crossref_primary_10_2139_ssrn_4052368 crossref_primary_10_3390_jcm13164621 crossref_primary_10_1177_17474930231184366 crossref_primary_10_3390_jcm11247423 crossref_primary_10_1097_FJC_0000000000001360 crossref_primary_10_23736_S2724_5683_23_06275_0 crossref_primary_10_36660_abc_20240590 crossref_primary_10_3390_diagnostics12102520 crossref_primary_10_1007_s10309_022_00478_9 crossref_primary_10_1016_j_amjmed_2024_02_005 crossref_primary_10_3389_fcvm_2022_994085 crossref_primary_10_1161_JAHA_123_032454 crossref_primary_10_1186_s40001_024_01816_5 crossref_primary_10_1055_a_2105_8736 crossref_primary_10_26442_00403660_2021_12_201224 crossref_primary_10_1161_STROKEAHA_123_043011 crossref_primary_10_1093_eurheartj_ehab816 crossref_primary_10_26442_20751753_2022_1_201474 crossref_primary_10_3390_ijerph192316151 crossref_primary_10_17816_cardar321821 crossref_primary_10_3389_fcvm_2024_1367623 crossref_primary_10_1002_cpt_2649 crossref_primary_10_1111_imj_15786 crossref_primary_10_1055_a_2325_5658 crossref_primary_10_1007_s10557_024_07573_1 crossref_primary_10_1007_s10309_025_00745_5 crossref_primary_10_1055_a_2446_1348 crossref_primary_10_1055_s_0042_1760330 crossref_primary_10_1161_JAHA_123_034641 crossref_primary_10_1007_s10557_023_07495_4 crossref_primary_10_21886_2712_8156_2023_4_1_19_27 crossref_primary_10_3390_jcm12165342 crossref_primary_10_3390_antiox12061185 crossref_primary_10_36660_abc_20230671 crossref_primary_10_7759_cureus_25102 crossref_primary_10_1016_j_ppedcard_2022_101608 crossref_primary_10_1002_agm2_12214 crossref_primary_10_1016_j_jtha_2024_05_023 crossref_primary_10_1016_j_mayocp_2023_01_007 crossref_primary_10_1016_j_heliyon_2024_e41596 crossref_primary_10_1038_s41401_022_00892_9 crossref_primary_10_3390_jcm11030512 crossref_primary_10_2147_VHRM_S429995 crossref_primary_10_1055_a_2173_7729 crossref_primary_10_4244_AIJ_D_22_00040 crossref_primary_10_1007_s11239_025_03067_5 crossref_primary_10_1055_a_2055_5064 crossref_primary_10_1007_s40256_023_00622_4 crossref_primary_10_26442_20751753_2022_2_201537 crossref_primary_10_1097_nme_0000000000000054 crossref_primary_10_1007_s00059_021_05078_3 crossref_primary_10_1055_s_0041_1739411 crossref_primary_10_1177_10760296241260728 crossref_primary_10_1016_j_bulcan_2022_10_008 crossref_primary_10_3390_transplantology3030022 crossref_primary_10_3389_fphar_2023_1263975 crossref_primary_10_3389_fphar_2022_1049283 crossref_primary_10_51847_XsGf0mxp27 crossref_primary_10_3390_medicina58010058 crossref_primary_10_1080_14779072_2023_2276892 crossref_primary_10_1093_eurheartj_ehab706 crossref_primary_10_1002_agm2_12234 crossref_primary_10_1111_pace_14920 crossref_primary_10_1016_j_recesp_2023_01_011 crossref_primary_10_1177_17474930221124412 crossref_primary_10_1186_s13049_025_01334_1 crossref_primary_10_1097_HPC_0000000000000351 crossref_primary_10_4236_ojem_2023_113008 crossref_primary_10_1155_2024_2285722 crossref_primary_10_3389_fphar_2024_1432713 crossref_primary_10_1007_s00210_023_02388_7 crossref_primary_10_1161_JAHA_121_024119 crossref_primary_10_1055_s_0043_1774304 crossref_primary_10_36660_abc_20220707 crossref_primary_10_1055_a_1402_5103 crossref_primary_10_18087_cardio_2022_1_n1904 crossref_primary_10_3390_jcm11102705 crossref_primary_10_1146_annurev_pharmtox_032823_122811 crossref_primary_10_1161_CIRCULATIONAHA_122_061647 crossref_primary_10_2459_JCM_0000000000001673 crossref_primary_10_1007_s10006_025_01348_0 crossref_primary_10_3389_fphar_2024_1332147 crossref_primary_10_1001_jamanetworkopen_2022_43307 crossref_primary_10_1016_j_amjcard_2023_07_108 crossref_primary_10_1055_a_1715_5960 crossref_primary_10_4103_IJHR_IJHR_2_24 crossref_primary_10_1007_s00399_021_00820_0 crossref_primary_10_1097_CP9_0000000000000079 crossref_primary_10_1093_ehjcr_ytad157 crossref_primary_10_1016_j_jamda_2024_01_011 crossref_primary_10_1055_a_2544_7919 crossref_primary_10_1007_s00108_022_01418_5 crossref_primary_10_1007_s11886_023_01858_x crossref_primary_10_1161_CIRCOUTCOMES_122_008982 crossref_primary_10_1111_jdv_19154 crossref_primary_10_1111_epi_17822 crossref_primary_10_1155_2021_5520027 crossref_primary_10_3389_fcvm_2021_757587 crossref_primary_10_3390_diagnostics14192208 crossref_primary_10_3390_jcm12247574 crossref_primary_10_3390_jcm12093223 crossref_primary_10_1016_j_ijid_2022_06_059 crossref_primary_10_48057_hematologa_v27i1_525 crossref_primary_10_1007_s12471_021_01617_z crossref_primary_10_3390_jcm13061677 crossref_primary_10_1007_s00392_023_02261_w crossref_primary_10_1007_s40262_023_01222_w crossref_primary_10_1161_CIRCULATIONAHA_123_066279 crossref_primary_10_1016_j_heliyon_2024_e36922 crossref_primary_10_3389_fneur_2024_1372231 crossref_primary_10_3390_ijerph22010065 crossref_primary_10_1016_j_amjcard_2022_07_028 crossref_primary_10_36290_vnl_2023_027 crossref_primary_10_1016_j_jns_2023_120810 crossref_primary_10_3390_ph15091146 crossref_primary_10_1016_j_jfma_2023_02_012 crossref_primary_10_1016_j_rec_2024_09_008 crossref_primary_10_1038_s41569_024_01076_0 crossref_primary_10_1155_ijod_3384210 crossref_primary_10_1055_s_0043_1776989 crossref_primary_10_31083_j_rcm2406180 crossref_primary_10_1080_14779072_2023_2270909 crossref_primary_10_1093_eurheartj_ehae176 crossref_primary_10_1093_eurheartj_ehae177 crossref_primary_10_1016_j_ejca_2024_114263 crossref_primary_10_1093_ehjcr_ytad006 crossref_primary_10_1093_europace_euab303 crossref_primary_10_1055_s_0043_1762596 crossref_primary_10_1080_14737175_2024_2379413 crossref_primary_10_2459_JCM_0000000000001461 crossref_primary_10_1136_rapm_2024_105766 crossref_primary_10_1007_s11739_024_03553_3 crossref_primary_10_1155_2024_9694592 crossref_primary_10_18231_j_ijpp_2022_029 crossref_primary_10_1007_s40263_024_01077_0 crossref_primary_10_1159_000540107 crossref_primary_10_26599_1671_5411_2024_03_009 crossref_primary_10_3389_fphar_2022_814724 crossref_primary_10_1016_j_thromres_2022_08_007 crossref_primary_10_26442_00403660_2022_12_201994 crossref_primary_10_1055_a_2225_8914 crossref_primary_10_1055_a_2325_5923 crossref_primary_10_1093_cvr_cvac054 crossref_primary_10_1093_ejcts_ezae355 crossref_primary_10_1007_s40256_024_00628_6 crossref_primary_10_3390_jcm12154969 crossref_primary_10_1002_msc_1743 crossref_primary_10_1186_s40545_022_00453_9 crossref_primary_10_1371_journal_pone_0310322 crossref_primary_10_1161_CIRCULATIONAHA_122_062779 crossref_primary_10_1212_WNL_0000000000207422 crossref_primary_10_1016_j_eclinm_2022_101709 crossref_primary_10_1016_j_thromres_2022_01_003 crossref_primary_10_1016_j_thromres_2022_01_001 crossref_primary_10_3390_medicina59050881 crossref_primary_10_1002_cpt_2927 crossref_primary_10_1007_s10072_023_06992_6 crossref_primary_10_3389_fneur_2021_800524 crossref_primary_10_1080_03007995_2022_2141962 crossref_primary_10_3389_fcvm_2021_774109 crossref_primary_10_4070_kcj_2024_0154 crossref_primary_10_2174_0115734110289980240201073715 crossref_primary_10_1055_a_2215_3704 crossref_primary_10_1007_s00392_022_02042_x crossref_primary_10_1080_17512433_2023_2187376 crossref_primary_10_1016_j_semnephrol_2023_151478 crossref_primary_10_1002_rth2_12804 crossref_primary_10_1016_j_clinbiochem_2023_110613 crossref_primary_10_1097_JS9_0000000000002137 crossref_primary_10_3390_ph17020163 crossref_primary_10_1007_s00059_023_05205_2 crossref_primary_10_1007_s40266_023_01035_3 crossref_primary_10_1111_dom_15747 crossref_primary_10_1080_14779072_2022_2152329 crossref_primary_10_3390_medicina59071339 crossref_primary_10_1007_s40256_022_00524_x crossref_primary_10_1093_eurheartj_ehab672 crossref_primary_10_1055_a_2442_9673 crossref_primary_10_1007_s00399_022_00913_4 crossref_primary_10_1007_s40263_022_00971_9 crossref_primary_10_1038_s41598_023_29185_9 crossref_primary_10_1055_s_0043_1769735 crossref_primary_10_3390_jcm11195712 crossref_primary_10_1007_s00104_021_01568_6 crossref_primary_10_1053_j_ajkd_2023_08_017 crossref_primary_10_1093_eurheartjsupp_suae020 crossref_primary_10_1016_j_rccl_2022_07_007 crossref_primary_10_1016_j_tcm_2023_11_005 crossref_primary_10_1093_eurheartj_ehac515 crossref_primary_10_1016_j_hrthm_2024_12_008 crossref_primary_10_3390_jcm13133784 crossref_primary_10_1007_s40263_023_00990_0 crossref_primary_10_1177_10760296231213070 crossref_primary_10_1093_ehjcvp_pvac042 crossref_primary_10_1016_j_thromres_2024_05_006 crossref_primary_10_1016_j_jtha_2024_12_032 crossref_primary_10_36660_abchf_20220093 crossref_primary_10_1080_03007995_2022_2124073 crossref_primary_10_1007_s40256_024_00692_y crossref_primary_10_1053_j_seminoncol_2023_05_002 crossref_primary_10_2147_RMHP_S442353 crossref_primary_10_1253_circrep_CR_22_0076 crossref_primary_10_1007_s10840_024_01771_5 crossref_primary_10_1080_14796678_2024_2363063 crossref_primary_10_3390_jcm11113207 crossref_primary_10_1556_650_2022_32336 crossref_primary_10_1055_s_0044_1790258 crossref_primary_10_3390_jcdd9050126 crossref_primary_10_1007_s10557_022_07409_w crossref_primary_10_1093_ckj_sfae270 crossref_primary_10_1080_14740338_2024_2409698 crossref_primary_10_1161_JAHA_122_025723 crossref_primary_10_1055_a_2181_8122 crossref_primary_10_1016_j_ijcard_2024_132276 crossref_primary_10_1161_STROKEAHA_123_040447 crossref_primary_10_1007_s40261_022_01190_2 crossref_primary_10_1093_eurheartjsupp_suad110 crossref_primary_10_1177_00185787221122656 crossref_primary_10_1093_ckj_sfae029 crossref_primary_10_1016_j_rpth_2023_100196 crossref_primary_10_1161_JAHA_123_033513 crossref_primary_10_1177_11297298241227248 crossref_primary_10_1016_j_ijcard_2022_01_063 crossref_primary_10_4070_kcj_2024_0222 crossref_primary_10_1111_bcp_16159 crossref_primary_10_3389_fcvm_2024_1423336 crossref_primary_10_1093_eurheartj_suac020 crossref_primary_10_1001_jamanetworkopen_2024_3208 crossref_primary_10_1093_ehjcvp_pvae002 crossref_primary_10_1055_a_1933_1391 crossref_primary_10_1097_CRD_0000000000000889 crossref_primary_10_1111_bcp_15180 crossref_primary_10_1001_jamacardio_2022_1292 crossref_primary_10_1080_14740338_2024_2444579 crossref_primary_10_1080_14779072_2023_2271388 crossref_primary_10_3389_fphar_2021_679431 crossref_primary_10_1007_s10072_024_07485_w crossref_primary_10_1055_s_0042_1750385 crossref_primary_10_1093_ndt_gfac210 crossref_primary_10_26442_2075082X_2021_3_201077 crossref_primary_10_1016_j_hrthm_2024_03_017 crossref_primary_10_1080_14656566_2022_2149323 crossref_primary_10_1016_j_rpth_2023_100082 crossref_primary_10_1016_j_thromres_2022_08_027 crossref_primary_10_3389_fphar_2025_1505665 crossref_primary_10_2147_PPA_S469910 crossref_primary_10_1093_eurheartjsupp_suad004 crossref_primary_10_1080_17425255_2023_2287472 crossref_primary_10_1016_j_hrthm_2025_01_045 crossref_primary_10_1055_a_1987_3559 crossref_primary_10_1016_j_jhepr_2022_100667 crossref_primary_10_1016_j_rccl_2022_01_001 crossref_primary_10_36660_abc_20230671i crossref_primary_10_1093_eurheartj_suac015 crossref_primary_10_1080_14740338_2023_2291865 crossref_primary_10_1007_s11910_023_01266_2 crossref_primary_10_1016_j_jacep_2023_11_020 crossref_primary_10_1155_cdr_9923772 crossref_primary_10_1007_s00392_022_01996_2 crossref_primary_10_18087_cardio_2021_5_n1349 crossref_primary_10_2196_29481 crossref_primary_10_1055_a_2171_6892 crossref_primary_10_1111_bcp_16010 crossref_primary_10_1016_j_jaad_2024_01_096 crossref_primary_10_1007_s40119_024_00387_0 crossref_primary_10_12968_hmed_2022_0213 crossref_primary_10_1016_j_ijpharm_2023_123626 crossref_primary_10_3390_jcm13206094 crossref_primary_10_1093_eurheartj_suab150 crossref_primary_10_3390_jcm12206533 crossref_primary_10_1093_eurheartj_suab152 crossref_primary_10_1093_eurheartj_suab154 crossref_primary_10_1093_eurheartj_suab153 crossref_primary_10_1186_s12959_023_00562_8 crossref_primary_10_3343_alm_2024_0036 crossref_primary_10_1136_bmj_2024_079520 crossref_primary_10_1177_10600280231211306 crossref_primary_10_1177_10760296231153638 crossref_primary_10_1016_j_ijcard_2024_132118 crossref_primary_10_3389_fcvm_2023_1208979 crossref_primary_10_1093_eurheartj_ehad431 crossref_primary_10_3390_jcm11113008 crossref_primary_10_3389_fcvm_2022_1070806 crossref_primary_10_1177_20406223211056730 crossref_primary_10_1186_s12871_023_02276_w crossref_primary_10_1055_a_1814_2536 crossref_primary_10_3748_wjg_v29_i33_4962 crossref_primary_10_1016_j_hrcr_2022_12_007 crossref_primary_10_1111_liv_16177 crossref_primary_10_1016_j_jacasi_2022_05_005 crossref_primary_10_1097_CRD_0000000000000713 crossref_primary_10_1007_s00228_022_03424_w crossref_primary_10_1111_bcp_15265 crossref_primary_10_3389_fneur_2024_1458697 crossref_primary_10_1093_ageing_afad038 crossref_primary_10_1007_s00228_021_03236_4 crossref_primary_10_3390_diseases12010008 crossref_primary_10_12677_ACM_2023_1381798 crossref_primary_10_3389_fmed_2024_1273304 crossref_primary_10_1007_s11886_023_01940_4 crossref_primary_10_1001_jamacardio_2024_1793 crossref_primary_10_1016_j_critrevonc_2022_103599 crossref_primary_10_1016_j_ijcha_2023_101333 crossref_primary_10_1097_MCG_0000000000002089 crossref_primary_10_7748_ns_2023_e12012 crossref_primary_10_1016_j_tru_2024_100169 crossref_primary_10_1097_ACO_0000000000001349 crossref_primary_10_1016_j_pharmr_2025_100037 crossref_primary_10_1001_jamaneurol_2024_2057 crossref_primary_10_1016_j_ejim_2023_03_023 crossref_primary_10_23736_S0031_0808_24_05114_0 crossref_primary_10_1016_j_ejim_2022_01_014 crossref_primary_10_1093_ageing_afac192 crossref_primary_10_1093_ehjcvp_pvae042 crossref_primary_10_1093_ehjcvp_pvad079 crossref_primary_10_1007_s12325_023_02544_8 crossref_primary_10_2174_1871525720666220321120944 crossref_primary_10_1016_j_jacadv_2025_101612 crossref_primary_10_1093_ehjcvp_pvad070 crossref_primary_10_23736_S0392_9590_23_04947_7 crossref_primary_10_1016_j_jacep_2023_08_037 crossref_primary_10_1111_eci_13773 crossref_primary_10_1371_journal_pone_0301421 crossref_primary_10_1016_j_ijcha_2023_101229 crossref_primary_10_1016_j_blre_2024_101240 crossref_primary_10_1161_CIRCEP_121_007956 crossref_primary_10_3390_ijerph20021448 crossref_primary_10_1016_j_rpth_2024_102544 crossref_primary_10_1093_europace_euae043 crossref_primary_10_1016_j_ijcha_2023_101223 crossref_primary_10_1016_j_semerg_2023_102136 crossref_primary_10_3389_fcvm_2022_949732 crossref_primary_10_1093_eurheartj_ehac244 crossref_primary_10_1182_bloodadvances_2023012408 crossref_primary_10_1016_j_mayocp_2023_12_005 crossref_primary_10_1055_a_1834_4923 crossref_primary_10_1177_23969873231205673 crossref_primary_10_1097_MD_0000000000040258 crossref_primary_10_1177_10760296221132551 crossref_primary_10_2139_ssrn_4133622 crossref_primary_10_1007_s40261_024_01411_w crossref_primary_10_1097_MBC_0000000000001233 crossref_primary_10_1161_STROKEAHA_122_041555 crossref_primary_10_2147_VHRM_S410497 crossref_primary_10_3389_fphar_2024_1384213 crossref_primary_10_5937_Galmed2412058S crossref_primary_10_1016_j_ejim_2022_09_001 crossref_primary_10_1111_bcp_16211 crossref_primary_10_31083_j_fbs1403021 crossref_primary_10_1016_j_jep_2024_118997 crossref_primary_10_1055_a_1520_2309 crossref_primary_10_1093_eurheartj_ehad200 crossref_primary_10_3390_healthcare12141415 crossref_primary_10_1111_epi_18144 crossref_primary_10_1016_j_ejim_2024_02_034 crossref_primary_10_1093_europace_euad083 crossref_primary_10_1093_eurheartj_ehad203 crossref_primary_10_17816_2311_2905_1993 crossref_primary_10_1182_bloodadvances_2024013854 crossref_primary_10_3390_pharma4010006 crossref_primary_10_1016_j_phacli_2024_04_425 crossref_primary_10_3390_jcm11102693 crossref_primary_10_1055_a_2132_9580 crossref_primary_10_1136_heartjnl_2023_322492 crossref_primary_10_3389_fphar_2023_1210560 crossref_primary_10_1016_j_revmed_2023_07_005 crossref_primary_10_1177_21501319221118806 crossref_primary_10_1111_jgh_16853 crossref_primary_10_1186_s12872_023_03415_4 crossref_primary_10_3390_nu14173652 crossref_primary_10_1007_s00392_023_02330_0 crossref_primary_10_1093_ehjcvp_pvad091 crossref_primary_10_1001_jamanetworkopen_2024_58742 crossref_primary_10_3390_pharmaceutics14081744 crossref_primary_10_1016_j_rpth_2024_102521 crossref_primary_10_1186_s12911_022_01783_z crossref_primary_10_1007_s00228_022_03300_7 crossref_primary_10_1007_s11239_023_02772_3 crossref_primary_10_1093_europace_euad057 crossref_primary_10_1111_bcp_15478 crossref_primary_10_1002_jssc_202300084 crossref_primary_10_1136_bmjopen_2021_058378 crossref_primary_10_1093_ehjcvp_pvae097 crossref_primary_10_1016_j_vph_2022_107123 crossref_primary_10_1007_s11560_023_00654_6 crossref_primary_10_4070_kcj_2024_0084 crossref_primary_10_1016_j_ijcard_2023_131188 crossref_primary_10_3390_jcm11195898 crossref_primary_10_3390_jvd2020017 crossref_primary_10_31083_j_rcm2308286 crossref_primary_10_3389_fphar_2024_1519869 crossref_primary_10_1016_j_jacc_2023_09_831 crossref_primary_10_1093_ejcts_ezad340 crossref_primary_10_1007_s11897_022_00563_0 crossref_primary_10_1016_j_mayocp_2023_07_013 crossref_primary_10_1055_s_0043_1778104 crossref_primary_10_1080_14779072_2024_2416666 crossref_primary_10_1111_bcp_15582 crossref_primary_10_3390_jcm12031224 crossref_primary_10_3389_fphar_2024_1304139 crossref_primary_10_1371_journal_pone_0308022 crossref_primary_10_1007_s00228_022_03357_4 crossref_primary_10_1007_s44266_023_00063_x crossref_primary_10_1016_j_jacadv_2023_100569 crossref_primary_10_3390_jcm13010216 crossref_primary_10_3390_jcm14031006 crossref_primary_10_15406_jccr_2021_14_00531 crossref_primary_10_3389_fphar_2023_1290785 crossref_primary_10_1371_journal_pone_0319342 crossref_primary_10_1097_CD9_0000000000000123 crossref_primary_10_1177_20420986241227014 crossref_primary_10_1007_s40258_023_00842_4 crossref_primary_10_1002_ana_26642 crossref_primary_10_3389_fphar_2021_769251 crossref_primary_10_1186_s40959_024_00243_z crossref_primary_10_1111_bcp_15570 crossref_primary_10_3389_fneur_2024_1294022 crossref_primary_10_1007_s00228_024_03629_1 crossref_primary_10_1093_europace_euad272 crossref_primary_10_1002_rth2_12680 crossref_primary_10_3390_jcm11144089 crossref_primary_10_1007_s11739_023_03299_4 crossref_primary_10_1016_j_acvd_2024_12_003 crossref_primary_10_1097_JCN_0000000000001159 crossref_primary_10_4244_EIJ_D_23_01100 crossref_primary_10_1007_s12325_024_03099_y crossref_primary_10_3390_jcm11206022 crossref_primary_10_1007_s44179_024_00266_y crossref_primary_10_1016_j_cpcardiol_2023_102181 crossref_primary_10_1111_pace_14381 crossref_primary_10_1055_a_2202_4296 crossref_primary_10_1080_17425255_2024_2352466 crossref_primary_10_3389_fneur_2022_907912 crossref_primary_10_1007_s10067_024_07048_6 crossref_primary_10_1016_j_hjc_2023_04_008 crossref_primary_10_1080_14779072_2023_2272652 crossref_primary_10_1055_a_1879_9266 crossref_primary_10_1007_s11739_023_03266_z crossref_primary_10_3390_jcm12185955 crossref_primary_10_3390_jcm14041377 crossref_primary_10_1016_j_rec_2023_03_003 crossref_primary_10_1093_eurheartj_ehae615 crossref_primary_10_3390_medicina58101355 crossref_primary_10_1016_j_rcsop_2024_100507 crossref_primary_10_1002_ca_24125 crossref_primary_10_1002_ca_24246 crossref_primary_10_1093_europace_euad288 crossref_primary_10_1007_s40199_021_00417_5 crossref_primary_10_1007_s40265_024_02077_6 crossref_primary_10_1016_j_rpth_2023_100137 crossref_primary_10_31083_j_rcm2507257 crossref_primary_10_1186_s13643_022_02098_w crossref_primary_10_31083_j_rcm2310346 crossref_primary_10_1016_j_echo_2023_05_011 crossref_primary_10_1002_pds_5733 crossref_primary_10_1016_j_blre_2024_101171 crossref_primary_10_1016_S1474_4422_23_00331_9 crossref_primary_10_1016_j_recesp_2022_10_017 crossref_primary_10_1016_j_jtha_2023_07_011
Cites_doi	10.1016/j.eplepsyres.2020.106304 10.1093/eurheartj/ehu083 10.1161/CIRCULATIONAHA.116.025257 10.1177/1060028018781853 10.1001/jamacardio.2016.1025 10.1161/CIRCULATIONAHA.113.006426 10.1111/jth.13184 10.1016/j.hrthm.2020.09.018 10.1111/jth.13323 10.1161/STROKEAHA.111.624650 10.1161/CIRCEP.113.000320 10.1161/JAHA.119.012540 10.1161/CIRCOUTCOMES.119.006212 10.1016/j.hrtlng.2014.03.004 10.1056/NEJMc1215900 10.1016/j.jacc.2020.12.053 10.1002/jcph.540 10.1016/j.cjca.2018.08.026 10.1093/eurheartj/ehx419 10.1124/dmd.107.019083 10.1371/journal.pone.0064255 10.1111/jce.13388 10.1002/jcph.1040 10.1160/TH12-12-0898 10.1056/NEJMoa1300615 10.1007/s40262-013-0100-7 10.1161/STROKEAHA.118.020232 10.1371/journal.pone.0180997 10.1182/bloodadvances.2019000972 10.1016/j.jcin.2016.10.023 10.1503/cmaj.050051 10.1007/s11239-015-1310-7 10.1016/j.jacc.2020.08.041 10.1093/eurheartj/ehaa612 10.1177/1076029617693940 10.1161/STROKEAHA.116.013880 10.1093/europace/eux087 10.1093/eurheartj/ehy776 10.1016/j.pec.2020.06.016 10.1093/ehjcvp/pvy041 10.1016/j.jacc.2020.01.019 10.1055/s-0038-1627480 10.1161/CIRCULATIONAHA.113.004777 10.1093/europace/eux274 10.1016/S2352-3026(19)30086-9 10.2165/00003088-200847050-00001 10.1016/j.jacc.2017.09.1085 10.1093/eurheartj/ehz304 10.1152/ajprenal.2000.278.5.F817 10.1056/NEJMoa1700518 10.1159/000371449 10.1111/jth.13912 10.1002/clc.22596 10.1186/s12883-017-0900-8 10.1093/ageing/afx103 10.1136/bmjopen-2018-026645 10.1007/s11239-012-0811-x 10.1111/ejh.13383 10.1016/j.ahj.2019.03.013 10.1186/s12959-021-00259-w 10.1093/eurheartj/ehz190 10.1001/jama.2017.13883 10.1056/NEJMoa1915152 10.1016/j.ahj.2014.06.005 10.1055/s-0038-1668523 10.1161/JAHA.116.003932 10.1001/jamainternmed.2016.5954 10.1001/jama.2013.280521 10.1007/s00392-017-1102-5 10.1161/STROKEAHA.111.627067 10.1016/j.ahj.2016.05.007 10.1161/STROKEAHA.114.006025 10.1161/CIRCULATIONAHA.115.020950 10.1016/j.amjmed.2017.10.036 10.1016/j.amjcard.2018.02.045 10.1002/acn3.50834 10.1016/j.amjcard.2020.04.016 10.1093/eurheartj/ehy780 10.1111/j.1538-7836.2009.03678.x 10.1016/j.jacc.2019.10.059 10.1161/CIRCULATIONAHA.117.031658 10.1002/psp4.12184 10.1160/TH10-08-0552 10.1056/NEJMoa2012883 10.1161/STR.0000000000000211 10.1001/jama.2018.17242 10.1253/circj.CJ-14-0942 10.1016/j.cger.2014.04.001 10.1093/eurheartj/ehz386 10.1093/eurheartj/ehu305 10.1001/jamaneurol.2019.2099 10.1016/j.jacc.2014.09.051 10.1161/CIRCULATIONAHA.119.044059 10.1161/CIRCULATIONAHA.111.029017 10.1093/eurheartj/ehz425 10.1093/ejcts/ezx334 10.1016/j.jacc.2018.11.051 10.1016/j.jacc.2018.07.037 10.1016/j.jacc.2020.08.025 10.1160/TH11-11-0804 10.1016/j.amjmed.2016.02.028 10.1007/s00228-020-02896-y 10.1016/j.seizure.2017.03.009 10.1056/NEJMoa0906598 10.1093/europace/euz361 10.1016/j.ijcard.2017.08.010 10.1016/j.amjms.2019.07.013 10.1007/s11239-019-01973-z 10.1161/CIRCULATIONAHA.119.043308 10.1002/jcph.288 10.1016/j.jacc.2016.04.026 10.1016/S0140-6736(14)61943-7 10.1093/eurheartj/ehw124 10.1016/j.blre.2017.02.001 10.1161/01.STR.22.8.983 10.1056/NEJMoa1911425 10.1016/j.ahj.2010.03.027 10.1161/CIRCULATIONAHA.114.013445 10.7326/M17-2341 10.1093/eurheartj/ehv320 10.1016/j.ijcard.2016.11.277 10.1016/j.jacc.2018.05.066 10.1002/cpt.1072 10.1053/j.jvca.2016.09.002 10.1111/bcp.13092 10.1001/jama.292.20.2471 10.1177/0091270009351883 10.1016/j.amjcard.2017.03.028 10.2169/internalmedicine.53.2890 10.1182/blood.2019000998 10.1056/NEJMoa1910021 10.1161/CIRCULATIONAHA.118.037955 10.1056/NEJMoa1701005 10.1007/s11239-018-1792-1 10.1681/ASN.2007111207 10.1161/STROKEAHA.118.021990 10.1056/NEJM199309023291001 10.1161/STROKEAHA.112.652065 10.1093/gerona/56.3.M146 10.1160/TH11-08-0566 10.1053/j.ajkd.2015.01.022 10.1056/NEJMoa1500857 10.1093/eurheartj/ehv201 10.1177/0091270010370974 10.1056/NEJMoa1904143 10.1016/j.amjcard.2018.09.027 10.1111/j.1365-2125.2007.02899.x 10.1056/NEJMoa076016 10.1161/01.STR.0000208294.46968.a4 10.1007/978-1-60761-803-4_9 10.1002/ana.25489 10.1093/eurheartj/ehy176 10.1056/NEJMoa1707278 10.1016/j.ijcard.2012.08.036 10.1371/journal.pone.0213379 10.1186/s12877-019-1267-z 10.1182/blood-2016-08-731638 10.1182/blood-2011-11-393587 10.1007/s40262-017-0554-0 10.1016/S2352-3026(16)00023-5 10.1002/ana.25134 10.1097/FJC.0b013e31822f6c2b 10.1055/s-0038-1636541 10.1016/j.seizure.2020.05.024 10.1056/NEJMoa1306638 10.1016/j.acvd.2013.04.001 10.1161/CIRCRESAHA.116.308426 10.1097/ALN.0b013e318238c036 10.1002/ana.25740 10.1016/S0140-6736(08)60880-6 10.1007/s40266-020-00771-0 10.1161/STROKEAHA.118.023877 10.1093/eurheartj/ehz659 10.1016/j.jacc.2016.12.038 10.1016/j.amjmed.2016.12.033 10.1111/j.1365-2125.2006.02776.x 10.1016/j.jacc.2013.07.104 10.1016/j.amjmed.2011.10.017 10.1016/j.amjcard.2019.05.072 10.1161/JAHA.118.008987 10.1124/jpet.111.180240 10.1136/bmj.315.7122.1582 10.1016/j.ahj.2009.06.031 10.1097/TA.0000000000001245 10.1182/blood-2017-05-782060 10.1016/S1474-4422(18)30145-5 10.1056/NEJMoa1009638 10.1128/AAC.01201-17 10.1177/1358863X19883027 10.3389/fneur.2018.01067 10.1182/blood-2014-03-563577 10.1016/j.ahj.2018.07.006 10.1001/archinte.159.7.677 10.1161/CIRCHEARTFAILURE.112.000143 10.1161/CIRCULATIONAHA.115.019794 10.1056/NEJMoa1113572 10.1056/NEJMoa1915103 10.1016/S0140-6736(19)31872-0 10.1016/j.hrthm.2015.02.028 10.1161/CIRCULATIONAHA.112.115386 10.1002/phar.1417 10.1056/NEJM199409293311301 10.1056/NEJMoa1607887 10.1161/01.STR.0000209239.71702.ce 10.1016/j.ahj.2018.03.008 10.1007/s11239-018-1643-0 10.1161/JAHA.118.011358 10.1016/j.thromres.2015.10.016 10.1160/TH10-10-0679 10.1056/NEJMoa1113697 10.1016/j.jstrokecerebrovasdis.2017.12.020 10.1111/j.1538-7836.2011.04498.x 10.1016/j.chest.2015.11.026 10.1093/ehjqcco/qcy040 10.1016/j.jcin.2020.09.013 10.1160/TH11-10-0718 10.1093/europace/eux240 10.1093/europace/euv030 10.1212/WNL.0000000000005207 10.1056/NEJMoa1302507 10.1007/s40261-018-0693-6 10.1177/1060028018796604 10.2165/0003088-200948010-00001 10.1002/ccr3.2532 10.1136/jnnp-2017-317151 10.1093/eurheartj/ehx393 10.1111/j.1538-7836.2012.04859.x 10.1016/j.amjmed.2017.06.026 10.1001/jamanetworkopen.2020.3593 10.1159/000495577 10.1093/europace/euy046 10.1161/CIRCULATIONAHA.110.004747 10.4070/kcj.2017.0328 10.2165/11595320-000000000-00000 10.1161/STROKEAHA.118.023921 10.1161/STROKEAHA.117.018773 10.1056/NEJMoa1708454 10.1161/CIR.0000000000000665 10.1136/openhrt-2018-000800 10.1185/03007990802361499 10.1056/NEJMoa1814051 10.1097/MJT.0000000000000937 10.1002/clc.22971 10.1136/bmjopen-2018-022690 10.1093/ehjcvp/pvw032 10.1016/j.ahj.2020.01.010 10.1093/eurheartj/ehu139 10.1007/BF03256595 10.1016/j.ijcard.2018.03.060 10.1161/STROKEAHA.118.021047 10.1177/1747493016659671 10.2215/CJN.01860217 10.1001/jamacardio.2020.0652 10.1093/eurheartj/ehy148 10.1002/phar.1698 10.1093/eurheartj/ehv177 10.1111/bcp.12075 10.1080/14737175.2019.1636649 10.1097/FJC.0000000000000607 10.1007/s40256-020-00449-3 10.1161/STROKEAHA.118.023797 10.1161/CIRCULATIONAHA.114.014113 10.1016/j.amjmed.2020.03.019 10.1161/CIRCHEARTFAILURE.113.000212 10.1136/bmjopen-2019-031341 10.1016/j.jstrokecerebrovasdis.2018.09.015 10.1056/NEJMoa1007903 10.1161/STROKEAHA.113.004506 10.1002/rth2.12039 10.2165/00003088-200847010-00005 10.1016/S0140-6736(13)62343-0 10.1093/eurheartj/ehz657 10.1093/gerona/glq067 10.1186/s12959-020-00242-x 10.1093/eurheartj/ehr052 10.1159/000445328 10.1002/cpdd.123 10.1001/jamanetworkopen.2020.6424 10.1016/j.chest.2018.11.009 10.1161/STROKEAHA.119.026048 10.1111/j.1538-7836.2005.01204.x 10.1186/s12959-015-0057-x 10.1093/ehjcvp/pvz035 10.1017/S1041610218000583 10.1016/j.amjmed.2016.11.001 10.1056/NEJMoa1112277 10.1186/s12893-015-0096-z 10.1179/1074935715Z.00000000062 10.1253/circj.CJ-12-0454 10.1161/STROKEAHA.113.001701 10.1093/europace/euv190 10.1016/S0140-6736(16)30968-0 10.5853/jos.2016.00864 10.1002/pds.2141 10.1177/1076029613492876 10.1111/bcp.12541 10.1016/j.jcin.2014.06.014 10.1093/europace/euv288 10.1001/jamainternmed.2019.2431 10.1093/europace/euz259 10.1016/j.jemermed.2019.09.011 10.1093/eurheartj/ehy411 10.1161/STROKEAHA.113.000990 10.1161/CIRCULATIONAHA.113.005754 10.1111/jth.13815 10.1016/S0140-6736(17)32713-7 10.1016/j.amjcard.2007.06.034 10.7326/M19-3763 10.1093/europace/euv309 10.1046/j.1365-2141.2003.04652.x 10.3390/ijms19123879 10.1111/j.1538-7836.2007.02748.x 10.1093/eurheartj/ehaa509 10.1056/NEJMoa0800374 10.1111/j.1528-1167.2008.01945.x 10.1136/hrt.2011.224519 10.1161/CIRCULATIONAHA.113.002332 10.1055/s-0038-1657785 10.1111/jgs.15058 10.1161/STROKEAHA.114.005430 10.1016/j.jacc.2017.09.002 10.1056/NEJMoa1817083 10.1111/bcp.12393 10.1016/j.jacc.2020.04.067 10.1161/CIRCULATIONAHA.118.036046 10.1093/eurheartj/suaa102 10.1016/j.chest.2019.11.025 10.1016/j.ahj.2008.03.010 10.1056/NEJMoa1207541 10.1111/bcp.12114 10.1161/STROKEAHA.108.539619 10.1161/CIRCULATIONAHA.112.101808 10.1016/j.jamda.2017.08.014 10.1016/j.hrthm.2020.01.007 10.1124/dmd.109.029694 10.1161/JAHA.113.000200 10.1016/S0140-6736(98)04402-X 10.1111/1755-5922.12457 10.1007/s40256-013-0029-0 10.1093/europace/euaa192 10.1161/CIRCULATIONAHA.108.816082 10.1681/ASN.2016090980 10.1016/j.thromres.2019.04.007 10.1056/NEJMoa2029603 10.1212/CPJ.0000000000000425 10.1053/j.gastro.2016.08.054 10.1007/s11239-019-01866-1 10.1093/eurheartj/ehy784 10.1002/ejhf.595 10.1053/j.gastro.2015.05.002 10.1136/heartjnl-2020-317901 10.1161/JAHA.119.014177 10.1093/eurheartj/ehz059 10.1212/WNL.0000000000004407 10.1016/j.clpt.2005.06.011 10.1378/chest.13-0054 10.1002/joa3.12458 10.1016/j.jacc.2014.05.065 10.7326/0003-4819-115-4-256 10.1182/blood-2018-04-848333 10.1016/j.ahj.2017.08.017 10.1016/j.thromres.2014.09.011 10.1016/j.seizure.2010.12.012 10.1002/clc.23379 10.1093/eurheartj/ehz732 10.1177/2396987317705536 10.1001/jama.2017.21917 10.1111/ijlh.12807 10.1124/dmd.108.023143 10.1111/j.1365-2141.2008.07300.x 10.1016/j.hrthm.2016.12.036 10.1093/eurheartj/ehu046 10.1093/eurheartj/eht557 10.1111/jth.12969 10.1111/jocs.12074 10.3349/ymj.2019.60.3.277 10.1007/s11883-019-0808-4 10.1161/STROKEAHA.107.508580 10.1093/eurheartj/ehy236 10.1371/journal.pone.0149142 10.1016/j.chest.2017.02.009 10.1001/jamacardio.2019.6175 10.1136/pgmj.2005.041426 10.1056/NEJMoa1503943 10.1161/CIRCULATIONAHA.120.046534 10.1016/j.ahj.2017.08.011 10.1097/FTD.0000000000000064 10.1093/europace/eux275 10.1056/NEJMoa1501035 10.1016/j.amjcard.2014.10.005 10.1016/j.hrthm.2012.08.043 10.1111/bjh.15756 10.1111/ane.12934 10.1161/JAHA.118.009530 10.1016/j.ajem.2017.12.052 10.1093/europace/euw295 10.1016/j.ijcard.2016.02.005 10.1016/j.jacc.2007.01.098 10.1111/joim.12360 10.1161/CIRCULATIONAHA.108.832139 10.1016/j.jacc.2016.09.966 10.1093/eurheartj/ehx403 10.1001/jamacardio.2017.0364 10.1177/2396987319841187 10.1016/S1474-4422(17)30404-0 10.1016/j.thromres.2012.09.004 10.1093/eurheartj/ehy861 10.1016/j.ahj.2019.01.005 10.1097/ALN.0000000000001631 10.1177/0885066619882909 10.1056/NEJMoa1709118 10.1093/eurheartj/ehaa624 10.1161/STROKEAHA.119.025536 10.1177/0003319718791711 10.1161/CIRCULATIONAHA.117.029267 10.1161/CIRCOUTCOMES.119.005894 10.1182/bloodadvances.2017010694 10.1093/europace/euy054 10.1371/journal.pone.0191592 10.1093/eurheartj/ehy807 10.1177/030006051204000508 10.1016/j.thromres.2017.11.006 10.1182/bloodadvances.2020002335 10.1111/cob.12046 10.1002/pds.4896 10.1002/ccr3.809 10.1200/JCO.2018.78.8034 10.1081/CLT-100108492 10.1056/NEJMoa1409312 10.1093/eurheartj/ehy136 10.1007/s40266-017-0493-3 10.1161/STROKEAHA.110.589127 10.1007/s11695-013-0972-5 10.1055/s-0038-1668098 10.1161/STROKEAHA.119.028118 10.1097/CRD.0000000000000288 10.1097/FJC.0b013e3182970991 10.1056/NEJMoa1711948 10.1177/1076029617696582 10.1016/j.jacc.2016.12.031 10.1002/phar.2306 10.1056/NEJMoa1310907 10.1093/eurheartj/ehs274 10.1002/cam4.1054 10.1056/NEJMoa0905561 10.1002/jcph.1097 10.1007/s11239-016-1465-x 10.1161/CIRCULATIONAHA.111.090464 10.1182/blood-2014-08-595496 10.1111/jth.12149 10.1161/CIRCULATIONAHA.118.035418 10.1161/STROKEAHA.113.002968 10.1016/j.jacc.2020.04.053 10.1182/blood-2011-02-329979 10.1016/j.ijcard.2015.04.104 10.1093/europace/eut083 10.1177/0091270005274550 10.1161/STROKEAHA.119.028510 10.1111/bcp.12106 10.1016/j.ahj.2009.05.010 10.1056/NEJMoa1602002 10.1186/s12916-016-0718-z 10.1177/2396987319863606 10.1177/0091270006286904 10.1056/NEJMoa1007432 10.1016/j.clineuro.2019.04.013 10.1136/jnnp-2015-311849 10.1016/S2352-3026(19)30219-4 10.1001/jamacardio.2016.1829 10.1093/europace/eux288 10.1016/j.jacc.2009.04.091 10.1161/STROKEAHA.119.028030 10.12998/wjcc.v8.i5.928 10.1136/heartjnl-2016-310358 10.1212/01.wnl.0000238104.75563.2f 10.1212/WNL.0b013e3182364878 10.1161/CIRCULATIONAHA.113.005008 10.1055/s-0040-1716540 10.1007/s40261-015-0298-2 10.1161/CIRCULATIONAHA.114.014807 10.1177/0091270006296058 10.1161/CIRCULATIONAHA.114.012061 10.1016/S0140-6736(09)60734-0 10.1016/j.jacc.2015.07.026 10.2165/11318170-000000000-00000 10.1093/ageing/afl084 10.1093/eurheartj/ehw211 10.1016/S1474-4422(18)30356-9 10.1634/theoncologist.2013-0239 10.1056/NEJMoa1401105 10.1016/j.jacc.2016.11.061 10.1592/phco.28.12.1537 10.1056/NEJMoa1107039 10.1093/eurheartj/ehs167 10.1056/NEJMoa1105594 10.1161/STROKEAHA.116.015984 10.1093/eurheartj/ehx208 10.1182/asheducation.V2015.1.117.3916182 10.1111/jth.13513 10.1016/j.eplepsyres.2016.06.003 10.1161/CIRCULATIONAHA.118.035012 10.1007/s11886-018-1052-1 10.1016/j.hrthm.2020.07.022 10.1136/bmjopen-2020-037234 10.1016/j.jns.2014.09.008 10.1093/eurheartj/ehs267 10.1056/NEJMoa1611594 10.1053/j.gastro.2019.04.041 10.1093/eurheartj/ehx391 10.1016/j.jacc.2016.06.034 10.1111/jth.12599 10.1160/TH09-11-0758 10.1016/j.joa.2017.05.004 10.1182/blood-2011-05-353391 10.1097/FTD.0b013e3181f2f264 10.1016/j.clinthera.2016.05.004 10.1016/j.addr.2011.12.003 10.1016/j.jacc.2016.02.082 10.1016/j.ahj.2020.08.006 10.1111/j.1538-7836.2005.01304.x 10.1186/1477-9560-12-7 10.1016/j.jacc.2014.02.549 10.1016/S0140-6736(17)32155-4 10.1016/j.jocn.2011.02.018 10.1055/s-0039-1695771 10.1093/ejcts/ezx314 10.1182/blood-2017-04-778993 10.1177/1474515119845198 10.1161/STROKEAHA.120.028310
ContentType	Journal Article
Contributor	Chao, Tze-Fan Dagres, Nikolaos Field, Mark Hills, Mellanie True Lane, Deirdre A Atar, Dan Boriani, Giuseppe Deneke, Thomas Choi, Eue-Keun Joung, Boyoung Santos, Itamar de Souza Cole, Oana Maria Lip, Gregory Y H
Contributor_xml	– sequence: 1 givenname: Gregory Y H surname: Lip fullname: Lip, Gregory Y H – sequence: 2 givenname: Thomas surname: Deneke fullname: Deneke, Thomas – sequence: 3 givenname: Nikolaos surname: Dagres fullname: Dagres, Nikolaos – sequence: 4 givenname: Giuseppe surname: Boriani fullname: Boriani, Giuseppe – sequence: 5 givenname: Tze-Fan surname: Chao fullname: Chao, Tze-Fan – sequence: 6 givenname: Eue-Keun surname: Choi fullname: Choi, Eue-Keun – sequence: 7 givenname: Mellanie True surname: Hills fullname: Hills, Mellanie True – sequence: 8 givenname: Itamar de Souza surname: Santos fullname: Santos, Itamar de Souza – sequence: 9 givenname: Deirdre A surname: Lane fullname: Lane, Deirdre A – sequence: 10 givenname: Dan surname: Atar fullname: Atar, Dan – sequence: 11 givenname: Boyoung surname: Joung fullname: Joung, Boyoung – sequence: 12 givenname: Oana Maria surname: Cole fullname: Cole, Oana Maria – sequence: 13 givenname: Mark surname: Field fullname: Field, Mark
Copyright	Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com. 2021
Copyright_xml	– notice: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com. 2021
CorporateAuthor	External reviewers
CorporateAuthor_xml	– name: External reviewers
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTPV AOWAS DF2 ADTOC UNPAY
DOI	10.1093/europace/euab065
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Uppsala universitet Unpaywall for CDI: Periodical Content Unpaywall
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1532-2092
EndPage	1676
ExternalDocumentID	10.1093/europace/euab065 oai_DiVA_org_uu_459047 PMC11636576 33895845 10_1093_europace_euab065
Genre	Journal Article
GrantInformation_xml	– fundername: ;
GroupedDBID	--- --K .2P .I3 .XZ .ZR 0R~ 1B1 1TH 29G 2WC 4.4 48X 53G 5GY 5VS 5WA 6PF 70D AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPNW AAPQZ AAPXW AASNB AAUAY AAUQX AAVAP AAWTL ABEUO ABIXL ABJNI ABKDP ABNHQ ABNKS ABPTD ABQLI ABQTQ ABWST ABXVV ABZBJ ACGFS ACPRK ACUFI ACUTO ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADJQC ADOCK ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AFXEN AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHXPO AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C1A CAG CDBKE COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IHE IOX J21 KBUDW KOP KQ8 KSI KSN M-Z M41 M49 MHKGH N9A NGC NOMLY NOYVH NQ- NTWIH NU- O0~ O9- OAUYM OAWHX ODMLO OJQWA OJZSN OK1 OPAEJ OVD P2P PAFKI PEELM PQQKQ Q1. Q5Y RD5 RHF RIG ROL ROX RPM RPZ RUSNO RW1 RXO SEL SV3 TCURE TEORI TJX TOX TR2 UHS VVN W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 AAYXX ABEJV ABGNP ABPQP ABVGC AEMQT ALXQX AMNDL CITATION JXSIZ CGR CUY CVF ECM EIF NPM 7X8 5PM ADTPV AOWAS DF2 ADTOC UNPAY
ID	FETCH-LOGICAL-c498t-b0f02e85093d532a82f54e20dc205ff748f0b6b0ac2099856554e852456faa113
IEDL.DBID	UNPAY
ISSN	1099-5129 1532-2092
IngestDate	Wed Aug 20 00:14:04 EDT 2025 Thu Aug 21 06:29:26 EDT 2025 Thu Aug 21 18:29:32 EDT 2025 Fri Jul 11 02:25:28 EDT 2025 Sat May 31 02:06:46 EDT 2025 Thu Apr 24 23:05:47 EDT 2025 Wed Oct 01 06:03:12 EDT 2025 Wed Aug 28 03:19:57 EDT 2024
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	10
Keywords	NOACs dabigatran rivaroxaban DOACs apixaban edoxaban
Language	English
License	This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c498t-b0f02e85093d532a82f54e20dc205ff748f0b6b0ac2099856554e852456faa113
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://proxy.k.utb.cz/login?url=https://academic.oup.com/europace/article-pdf/23/10/1612/40544687/euab065.pdf
PMID	33895845
PQID	2518740908
PQPubID	23479
PageCount	65
ParticipantIDs	unpaywall_primary_10_1093_europace_euab065 swepub_primary_oai_DiVA_org_uu_459047 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11636576 proquest_miscellaneous_2518740908 pubmed_primary_33895845 crossref_citationtrail_10_1093_europace_euab065 crossref_primary_10_1093_europace_euab065 oup_primary_10_1093_europace_euab065
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	2021-10-09
PublicationDateYYYYMMDD	2021-10-09
PublicationDate_xml	– month: 10 year: 2021 text: 2021-10-09 day: 09
PublicationDecade	2020
PublicationPlace	England
PublicationPlace_xml	– name: England
PublicationTitle	Europace (London, England)
PublicationTitleAlternate	Europace
PublicationYear	2021
Publisher	Oxford University Press
Publisher_xml	– name: Oxford University Press
References	Reinecke (2025052700565188800_euab065-B144) 2018; 8 Søgaard (2025052700565188800_euab065-B357) 2019; 8 Kang (2025052700565188800_euab065-B474) 2017; 17 De Vriese (2025052700565188800_euab065-B138) 2015; 66 Tripodi (2025052700565188800_euab065-B210) 2016; 14 von Oertzen (2025052700565188800_euab065-B435) 2019; 40 Van Mieghem (2025052700565188800_euab065-B29) 2018; 205 Tomaselli (2025052700565188800_euab065-B174) 2020; 76 Hanni (2025052700565188800_euab065-B125) 2020; 4 Chan (2025052700565188800_euab065-B145) 2016; 67 Kubitza (2025052700565188800_euab065-B520) 2005; 78 Cannistraro (2025052700565188800_euab065-B305) 2018; 20 Shah (2025052700565188800_euab065-B491) 2018; 2 Vranckx (2025052700565188800_euab065-B245) 2019; 394 Eerenberg (2025052700565188800_euab065-B192) 2011; 124 Halperin (2025052700565188800_euab065-B315) 2014; 130 Lee (2025052700565188800_euab065-B55) 2019; 50 Lee (2025052700565188800_euab065-B276) 2018; 121 Mauri (2025052700565188800_euab065-B263) 2014; 371 Wang (2025052700565188800_euab065-B469) 2019; 47 Lindhoff-Last (2025052700565188800_euab065-B552) 2010; 32 Goodman-Casanova (2025052700565188800_euab065-B364) 2019; 19 Giugliano (2025052700565188800_euab065-B282) 2014; 45 Bauersachs (2025052700565188800_euab065-B501) 2010; 363 Connolly (2025052700565188800_euab065-B346) 2014; 45 Stangier (2025052700565188800_euab065-B107) 2008; 47 Parasrampuria (2025052700565188800_euab065-B407) 2015; 55 Avezum (2025052700565188800_euab065-B463) 2018; 5 Galgani (2025052700565188800_euab065-B541) 2018; 9 Garcia-Ptacek (2025052700565188800_euab065-B360) 2018; 19 Baumgartner (2025052700565188800_euab065-B13) 2017; 38 Undas (2025052700565188800_euab065-B77) 2020; 130 Colonna (2025052700565188800_euab065-B209) 2020; 43 Beyer-Westendorf (2025052700565188800_euab065-B186) 2014; 124 Stangier (2025052700565188800_euab065-B404) 2005; 45 Calkins (2025052700565188800_euab065-B224) 2017; 376 Varenne (2025052700565188800_euab065-B262) 2018; 391 Chiang (2025052700565188800_euab065-B4) 2017; 33 Dangas (2025052700565188800_euab065-B30) 2020; 382 Enriquez (2025052700565188800_euab065-B180) 2016; 18 Eriksson (2025052700565188800_euab065-B396) 2009; 48 Cowan (2025052700565188800_euab065-B52) 2018; 39 Mendell (2025052700565188800_euab065-B523) 2013; 13 Okumura (2025052700565188800_euab065-B332) 2017; 194 Graham (2025052700565188800_euab065-B319) 2016; 176 Cocca (2025052700565188800_euab065-B349) 2019; 57 Tsai (2025052700565188800_euab065-B547) 2013; 8 Harenberg (2025052700565188800_euab065-B151) 2019; 45 Hindricks (2025052700565188800_euab065-B1) 2021; 42 Siontis (2025052700565188800_euab065-B142) 2018; 138 Hesdorffer (2025052700565188800_euab065-B423) 2009; 50 Patel (2025052700565188800_euab065-B46) 2011; 365 Mueck (2025052700565188800_euab065-B94) 2013; 76 Shah (2025052700565188800_euab065-B329) 2019; 12 Chen (2025052700565188800_euab065-B303) 2018; 19 Torn (2025052700565188800_euab065-B231) 2003; 123 Kajy (2025052700565188800_euab065-B267) 2020; 27 Roffi (2025052700565188800_euab065-B265) 2016; 37 Guo (2025052700565188800_euab065-B45) 2020; 133 Cuker (2025052700565188800_euab065-B154) 2014; 64 Bonaca (2025052700565188800_euab065-B264) 2015; 372 De Caterina (2025052700565188800_euab065-B414) 2017; 106 Eriksson (2025052700565188800_euab065-B509) 2007; 5 Oldgren (2025052700565188800_euab065-B256) 2019; 40 Dagres (2025052700565188800_euab065-B352) 2018; 20 Lavie (2025052700565188800_euab065-B368) 2017; 70 Apostolakis (2025052700565188800_euab065-B441) 2013; 144 Chan (2025052700565188800_euab065-B399) 2014; 34 Boriani (2025052700565188800_euab065-B381) 2019; 40 Dowlatshahi (2025052700565188800_euab065-B176) 2012; 43 Zada (2025052700565188800_euab065-B199) 2021; 36 Fanaroff (2025052700565188800_euab065-B128) 2018; 39 Miao (2025052700565188800_euab065-B143) 2020; 104 Frost (2025052700565188800_euab065-B524) 2017; 9 Safouris (2025052700565188800_euab065-B387) 2014; 346 Stangier (2025052700565188800_euab065-B184) 2010; 49 Leung (2025052700565188800_euab065-B425) 2017; 88 Patel (2025052700565188800_euab065-B158) 2019; 184 Prins (2025052700565188800_euab065-B502) 2012; 366 Hori (2025052700565188800_euab065-B453) 2013; 44 Ge (2025052700565188800_euab065-B228) 2018; 36 Boriani (2025052700565188800_euab065-B382) 2021; 121 Salmonson (2025052700565188800_euab065-B152) 2017; 3 Bassand (2025052700565188800_euab065-B331) 2019; 139 Abed (2025052700565188800_euab065-B370) 2013; 310 Steffel (2025052700565188800_euab065-B70) 2016; 68 Kirchhof (2025052700565188800_euab065-B11) 2016; 18 Zou (2025052700565188800_euab065-B417) 2015; 22 Sanchis-Gomar (2025052700565188800_euab065-B88) 2020; 41 Seiffge (2025052700565188800_euab065-B290) 2019; 18 Liesenfeld (2025052700565188800_euab065-B375) 2011; 9 Mendell (2025052700565188800_euab065-B536) 2013; 62 Stollberger (2025052700565188800_euab065-B544) 2014; 43 Douxfils (2025052700565188800_euab065-B157) 2013; 110 Devereaux (2025052700565188800_euab065-B219) 2014; 370 Man-Son-Hing (2025052700565188800_euab065-B344) 1999; 159 Green (2025052700565188800_euab065-B206) 2001; 39 Wiggins (2025052700565188800_euab065-B543) 2016; 36 Holtkamp (2025052700565188800_euab065-B421) 2017; 2 Potpara (2025052700565188800_euab065-B437) 2019; 40 Lane (2025052700565188800_euab065-B74) 2018; 41 2025052700565188800_euab065-B183 Rietbrock (2025052700565188800_euab065-B310) 2008; 156 Connolly (2025052700565188800_euab065-B48) 2009; 361 Singh-Manoux (2025052700565188800_euab065-B354) 2017; 38 Okumura (2025052700565188800_euab065-B85) 2017; 40 McMurray (2025052700565188800_euab065-B38) 2013; 6 Tittl (2025052700565188800_euab065-B391) 2018; 262 Avezum (2025052700565188800_euab065-B17) 2015; 132 Calkins (2025052700565188800_euab065-B230) 2018; 20 LaHaye (2025052700565188800_euab065-B96) 2012; 33 Kubitza (2025052700565188800_euab065-B525) 2006; 46 Fried (2025052700565188800_euab065-B337) 2001; 56 van Tuijl (2025052700565188800_euab065-B422) 2011; 20 He (2025052700565188800_euab065-B475) 2020; 8 Myint (2025052700565188800_euab065-B415) 2006; 82 Biffi (2025052700565188800_euab065-B302) 2020; 51 Hohnloser (2025052700565188800_euab065-B225) 2019; 40 Di Minno (2025052700565188800_euab065-B545) 2017; 31 Di Biase (2025052700565188800_euab065-B222) 2014; 129 Martin (2025052700565188800_euab065-B383) 2016; 14 Schullo-Feulner (2025052700565188800_euab065-B401) 2014; 4 Yao (2025052700565188800_euab065-B50) 2016 Sousa-Uva (2025052700565188800_euab065-B235) 2018; 53 Kearon (2025052700565188800_euab065-B471) 2016; 149 Henrard (2025052700565188800_euab065-B314) 2017; 34 Kubitza (2025052700565188800_euab065-B105) 2006; 46 (2025052700565188800_euab065-B173) 1993; 329 Song (2025052700565188800_euab065-B193) 2017; 15 Scotti (2025052700565188800_euab065-B347) Frost (2025052700565188800_euab065-B526) 2015; 79 Haas (2025052700565188800_euab065-B56) 2019; 213 Sibbing (2025052700565188800_euab065-B257) 2017; 390 Mazurek (2025052700565188800_euab065-B58) 2019; 22 2025052700565188800_euab065-B365 Wang (2025052700565188800_euab065-B433) 2020; 6 Schelleman (2025052700565188800_euab065-B540) 2011; 20 Shaw (2025052700565188800_euab065-B211) 2020; 4 Barba (2025052700565188800_euab065-B411) 2005; 3 Moore (2025052700565188800_euab065-B112) 2014; 3 Deo (2025052700565188800_euab065-B241) 2013; 28 Collet (2025052700565188800_euab065-B254) 2020 Bansal (2025052700565188800_euab065-B117) 2017; 12 Lip (2025052700565188800_euab065-B99) 2014; 111 Eikelboom (2025052700565188800_euab065-B516) 2017; 377 Wolf (2025052700565188800_euab065-B312) 1991; 22 2025052700565188800_euab065-B496 Gerner (2025052700565188800_euab065-B200) 2018; 83 Mendell (2025052700565188800_euab065-B532) 2015; 35 Tiedemann (2025052700565188800_euab065-B555) 2010; 65 Chan (2025052700565188800_euab065-B140) 2015; 131 Godier (2025052700565188800_euab065-B190) 2012; 116 Deng (2025052700565188800_euab065-B487) 2019; 8 Seeger (2025052700565188800_euab065-B26) 2017; 10 2025052700565188800_euab065-B92 Cha (2025052700565188800_euab065-B456) 2017; 48 Majeed (2025052700565188800_euab065-B167) 2013; 128 Lee (2025052700565188800_euab065-B175) 2006; 67 Walenga (2025052700565188800_euab065-B481) 2013; 19 Greenblatt (2025052700565188800_euab065-B527) 2018; 58 Giugliano (2025052700565188800_euab065-B168) 2016; 129 Eikelboom (2025052700565188800_euab065-B15) 2013; 369 Suzuki (2025052700565188800_euab065-B163) 2020; 76 Jacquemin (2025052700565188800_euab065-B160) 2018; 40 Moudallel (2025052700565188800_euab065-B72) 2021; 104 Renda (2025052700565188800_euab065-B22) 2017; 69 Amarenco (2025052700565188800_euab065-B64) 2019; 5 Steffel (2025052700565188800_euab065-B122) 2012; 33 Rubenstein (2025052700565188800_euab065-B342) 2006; 35(Suppl 2 Shen (2025052700565188800_euab065-B445) 2008; 39 De Caterina (2025052700565188800_euab065-B20) 2017; 69 Hori (2025052700565188800_euab065-B101) 2012; 76 Kim (2025052700565188800_euab065-B492) 2018; 48 Wallace (2025052700565188800_euab065-B373) 2013; 36 Turpie (2025052700565188800_euab065-B515) 2009; 373 Kato (2025052700565188800_euab065-B69) 2016 Pokorney (2025052700565188800_euab065-B133) 2020; 75 Haeusler (2025052700565188800_euab065-B221) 2012; 43 Rockwood (2025052700565188800_euab065-B338) 1999; 353 Reinecke (2025052700565188800_euab065-B121) 2009; 20 Dalia (2025052700565188800_euab065-B269) 2021 Schulman (2025052700565188800_euab065-B504) 2013; 368 2025052700565188800_euab065-B207 Hankey (2025052700565188800_euab065-B464) 2014; 45 Van Spall (2025052700565188800_euab065-B556) 2012; 126 Magnani (2025052700565188800_euab065-B39) 2016; 18 Diener (2025052700565188800_euab065-B86) 2017; 38 Feeney (2025052700565188800_euab065-B348) 2016; 81 Yang (2025052700565188800_euab065-B275) 2019; 358 Lee (2025052700565188800_euab065-B299) 2020; 51 Burnett (2025052700565188800_euab065-B384) 2016; 41 Lip (2025052700565188800_euab065-B59) 2018; 49 Gillinov (2025052700565188800_euab065-B238) 2016; 374 Kido (2025052700565188800_euab065-B393) 2019; 53 Stefanidou (2025052700565188800_euab065-B419) 2017; 47 Young (2025052700565188800_euab065-B467) 2018; 36 Bonde (2025052700565188800_euab065-B130) 2014; 64 Burn (2025052700565188800_euab065-B416) 1997; 315 Eche (2025052700565188800_euab065-B236) 2019; 39 Acton (202505 34480553 - Europace. 2021 Oct 9;23(10):1685. doi: 10.1093/europace/euab217. 34549782 - Europace. 2021 Oct 9;23(10):1686. doi: 10.1093/europace/euab219. 34179979 - Europace. 2021 Oct 9;23(10):1676. doi: 10.1093/europace/euab157. 34549781 - Europace. 2021 Oct 9;23(10):1686-1687. doi: 10.1093/europace/euab220. 34480550 - Europace. 2021 Oct 9;23(10):1685-1686. doi: 10.1093/europace/euab218.
References_xml	– volume: 162 start-page: 106304 year: 2020 ident: 2025052700565188800_euab065-B431 article-title: The interactions between anticonvulsants and non-vitamin K antagonist oral anticoagulant agents: a systematic review publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2020.106304 – volume: 35 start-page: 1873 year: 2014 ident: 2025052700565188800_euab065-B166 article-title: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu083 – volume: 134 start-page: 1909 year: 2016 ident: 2025052700565188800_euab065-B534 article-title: Antiretroviral boosting agent cobicistat increases the pharmacokinetic exposure and anticoagulant effect of dabigatran in HIV-negative healthy volunteers publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.025257 – volume: 52 start-page: 1078 year: 2018 ident: 2025052700565188800_euab065-B141 article-title: Safety and efficacy of apixaban versus warfarin in patients with advanced chronic kidney disease publication-title: Ann Pharmacother doi: 10.1177/1060028018781853 – volume: 1 start-page: 433 year: 2016 ident: 2025052700565188800_euab065-B459 article-title: Racial differences in atrial fibrillation-related cardiovascular disease and mortality: the Atherosclerosis Risk in Communities (ARIC) study publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2016.1025 – volume: 129 start-page: 2638 year: 2014 ident: 2025052700565188800_euab065-B222 article-title: Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.006426 – volume: 14 start-page: 65 year: 2016 ident: 2025052700565188800_euab065-B409 article-title: Obesity and risk of bleeding: the SMART study publication-title: J Thromb Haemost doi: 10.1111/jth.13184 – volume: 18 start-page: 297 year: 2021 ident: 2025052700565188800_euab065-B32 article-title: Anticoagulation for stroke prevention in patients with hypertrophic cardiomyopathy and atrial fibrillation: a review publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2020.09.018 – volume: 14 start-page: 1308 year: 2016 ident: 2025052700565188800_euab065-B383 article-title: Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH publication-title: J Thromb Haemost doi: 10.1111/jth.13323 – volume: 42 start-page: 3594 year: 2011 ident: 2025052700565188800_euab065-B188 article-title: Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran publication-title: Stroke doi: 10.1161/STROKEAHA.111.624650 – volume: 6 start-page: 460 year: 2013 ident: 2025052700565188800_euab065-B232 article-title: Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.113.000320 – volume: 8 start-page: e012540 year: 2019 ident: 2025052700565188800_euab065-B487 article-title: Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with cancer and atrial fibrillation: a systematic review and meta-analysis publication-title: J Am Heart Assoc doi: 10.1161/JAHA.119.012540 – volume: 12 start-page: e006212 year: 2019 ident: 2025052700565188800_euab065-B329 article-title: Net clinical benefit of oral anticoagulation among older adults with atrial fibrillation publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.119.006212 – volume: 43 start-page: 262 year: 2014 ident: 2025052700565188800_euab065-B544 article-title: Prolonged anticoagulant activity of rivaroxaban in a polymorbid elderly female with non-convulsive epileptic state publication-title: Heart Lung doi: 10.1016/j.hrtlng.2014.03.004 – volume: 368 start-page: 2440 year: 2013 ident: 2025052700565188800_euab065-B386 article-title: Ischemic stroke in an obese patient receiving dabigatran publication-title: N Engl J Med doi: 10.1056/NEJMc1215900 – volume: 77 start-page: 1197 year: 2021 ident: 2025052700565188800_euab065-B100 article-title: Randomized, double-blind comparison of half-dose versus full-dose edoxaban in 14,014 patients with atrial fibrillation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.12.053 – volume: 55 start-page: 1286 year: 2015 ident: 2025052700565188800_euab065-B407 article-title: Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule publication-title: J Clin Pharmacol doi: 10.1002/jcph.540 – volume: 34 start-page: 1371 year: 2018 ident: 2025052700565188800_euab065-B3 article-title: 2018 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation publication-title: Can J Cardiol doi: 10.1016/j.cjca.2018.08.026 – volume: 39 start-page: 123 year: 2018 ident: 2025052700565188800_euab065-B75 article-title: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx419 – volume: 36 start-page: 386 year: 2008 ident: 2025052700565188800_euab065-B106 article-title: The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans publication-title: Drug Metab Dispos doi: 10.1124/dmd.107.019083 – volume: 8 start-page: e64255 year: 2013 ident: 2025052700565188800_euab065-B547 article-title: A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines publication-title: PLoS One doi: 10.1371/journal.pone.0064255 – volume: 29 start-page: 239 year: 2018 ident: 2025052700565188800_euab065-B369 article-title: Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.13388 – volume: 58 start-page: 533 year: 2018 ident: 2025052700565188800_euab065-B527 article-title: Impaired rivaroxaban clearance in mild renal insufficiency with verapamil coadministration: potential implications for bleeding risk and dose selection publication-title: J Clin Pharmacol doi: 10.1002/jcph.1040 – volume: 110 start-page: 283 year: 2013 ident: 2025052700565188800_euab065-B157 article-title: Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide publication-title: Thromb Haemost doi: 10.1160/TH12-12-0898 – volume: 369 start-page: 1206 year: 2013 ident: 2025052700565188800_euab065-B15 article-title: Dabigatran versus warfarin in patients with mechanical heart valves publication-title: N Engl J Med doi: 10.1056/NEJMoa1300615 – volume: 53 start-page: 1 year: 2014 ident: 2025052700565188800_euab065-B519 article-title: Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban publication-title: Clin Pharmacokinet doi: 10.1007/s40262-013-0100-7 – volume: 49 start-page: 2933 year: 2018 ident: 2025052700565188800_euab065-B59 article-title: Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients publication-title: Stroke doi: 10.1161/STROKEAHA.118.020232 – volume: 12 start-page: e0180997 year: 2017 ident: 2025052700565188800_euab065-B341 article-title: Falls, non-accidental falls and syncope in community-dwelling adults aged 50 years and older: implications for cardiovascular assessment publication-title: PLoS One doi: 10.1371/journal.pone.0180997 – volume: 4 start-page: 2366 year: 2020 ident: 2025052700565188800_euab065-B125 article-title: Outcomes associated with apixaban vs warfarin in patients with renal dysfunction publication-title: Blood Adv doi: 10.1182/bloodadvances.2019000972 – volume: 10 start-page: 66 year: 2017 ident: 2025052700565188800_euab065-B26 article-title: Apixaban in patients with atrial fibrillation after transfemoral aortic valve replacement publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2016.10.023 – volume: 173 start-page: 489 year: 2005 ident: 2025052700565188800_euab065-B339 article-title: A global clinical measure of fitness and frailty in elderly people publication-title: Cmaj doi: 10.1503/cmaj.050051 – volume: 41 start-page: 206 year: 2016 ident: 2025052700565188800_euab065-B384 article-title: Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-015-1310-7 – volume: 76 start-page: 1815 year: 2020 ident: 2025052700565188800_euab065-B91 article-title: Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.08.041 – volume: 42 start-page: 373 year: 2021 ident: 2025052700565188800_euab065-B1 article-title: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehaa612 – volume: 24 start-page: 525 year: 2018 ident: 2025052700565188800_euab065-B362 article-title: Drug adherence in patients with nonvalvular atrial fibrillation taking non-vitamin K antagonist oral anticoagulants in Turkey: NOAC-TR publication-title: Clin Appl Thromb Hemost doi: 10.1177/1076029617693940 – volume: 47 start-page: 2462 year: 2016 ident: 2025052700565188800_euab065-B447 article-title: Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation: a nationwide cohort study publication-title: Stroke doi: 10.1161/STROKEAHA.116.013880 – volume: 20 start-page: 569 year: 2018 ident: 2025052700565188800_euab065-B278 article-title: Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation publication-title: Europace doi: 10.1093/europace/eux087 – volume: 40 start-page: 1528 year: 2019 ident: 2025052700565188800_euab065-B450 article-title: Stroke prevention in AF: of Asians and non-Asians publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy776 – volume: 104 start-page: 155 year: 2021 ident: 2025052700565188800_euab065-B72 article-title: Association of conflicting information from healthcare providers and poor shared decision making with suboptimal adherence in direct oral anticoagulant treatment: a cross-sectional study in patients with atrial fibrillation publication-title: Patient Educ Couns doi: 10.1016/j.pec.2020.06.016 – volume: 5 start-page: 70 year: 2019 ident: 2025052700565188800_euab065-B64 article-title: Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS study publication-title: Eur Heart J Cardiovasc Pharmacother doi: 10.1093/ehjcvp/pvy041 – volume: 75 start-page: 1299 year: 2020 ident: 2025052700565188800_euab065-B133 article-title: Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and end-stage renal disease publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.01.019 – volume: 130 start-page: 47 year: 2020 ident: 2025052700565188800_euab065-B77 article-title: Bleeding in anticoagulated patients with atrial fibrillation: practical considerations publication-title: Pol Arch Intern Med – volume: 118 start-page: 437 year: 2018 ident: 2025052700565188800_euab065-B156 article-title: International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants publication-title: Thromb Haemost doi: 10.1055/s-0038-1627480 – volume: 129 start-page: 1196 year: 2014 ident: 2025052700565188800_euab065-B132 article-title: Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.004777 – volume: 20 start-page: e1 year: 2018 ident: 2025052700565188800_euab065-B220 article-title: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation publication-title: Europace doi: 10.1093/europace/eux274 – volume: 6 start-page: e359 year: 2019 ident: 2025052700565188800_euab065-B394 article-title: Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data publication-title: Lancet Haematol doi: 10.1016/S2352-3026(19)30086-9 – volume: 47 start-page: 285 year: 2008 ident: 2025052700565188800_euab065-B107 article-title: Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate publication-title: Clin Pharmacokinet doi: 10.2165/00003088-200847050-00001 – volume: 70 start-page: 3042 year: 2017 ident: 2025052700565188800_euab065-B203 article-title: 2017 ACC Expert Consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2017.09.1085 – ident: 2025052700565188800_euab065-B207 – volume: 40 start-page: 2327 year: 2019 ident: 2025052700565188800_euab065-B353 article-title: Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz304 – volume: 278 start-page: F817 year: 2000 ident: 2025052700565188800_euab065-B372 article-title: Glomerular hemodynamics in severe obesity publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.2000.278.5.F817 – volume: 376 start-page: 1211 year: 2017 ident: 2025052700565188800_euab065-B506 article-title: Rivaroxaban or aspirin for extended treatment of venous thromboembolism publication-title: N Engl J Med doi: 10.1056/NEJMoa1700518 – volume: 129 start-page: 197 year: 2015 ident: 2025052700565188800_euab065-B135 article-title: Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease publication-title: Nephron doi: 10.1159/000371449 – volume: 16 start-page: 209 year: 2018 ident: 2025052700565188800_euab065-B147 article-title: Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians publication-title: J Thromb Haemost doi: 10.1111/jth.13912 – volume: 40 start-page: 126 year: 2017 ident: 2025052700565188800_euab065-B85 article-title: Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation publication-title: Clin Cardiol doi: 10.1002/clc.22596 – volume: 17 start-page: 124 year: 2017 ident: 2025052700565188800_euab065-B474 article-title: Thrombocytopenia induced by dabigatran: two case reports publication-title: BMC Neurol doi: 10.1186/s12883-017-0900-8 – volume: 47 start-page: 9 year: 2018 ident: 2025052700565188800_euab065-B323 article-title: Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis publication-title: Age Ageing doi: 10.1093/ageing/afx103 – volume: 9 start-page: e026645 year: 2019 ident: 2025052700565188800_euab065-B57 article-title: Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016 publication-title: BMJ Open doi: 10.1136/bmjopen-2018-026645 – volume: 36 start-page: 96 year: 2013 ident: 2025052700565188800_euab065-B373 article-title: Comparison of initial warfarin response in obese patients versus non-obese patients publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-012-0811-x – volume: 104 start-page: 328 year: 2020 ident: 2025052700565188800_euab065-B143 article-title: Rivaroxaban versus apixaban in non-valvular atrial fibrillation patients with end-stage renal disease or receiving dialysis publication-title: Eur J Haematol doi: 10.1111/ejh.13383 – volume: 213 start-page: 35 year: 2019 ident: 2025052700565188800_euab065-B56 article-title: Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF publication-title: Am Heart J doi: 10.1016/j.ahj.2019.03.013 – year: 2021 ident: 2025052700565188800_euab065-B269 article-title: Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis publication-title: Thromb J doi: 10.1186/s12959-021-00259-w – volume: 40 start-page: 3013 year: 2019 ident: 2025052700565188800_euab065-B225 article-title: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz190 – ident: 2025052700565188800_euab065-B311 – volume: 318 start-page: 1250 year: 2017 ident: 2025052700565188800_euab065-B432 article-title: Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation publication-title: JAMA doi: 10.1001/jama.2017.13883 – volume: 382 start-page: 1696 year: 2020 ident: 2025052700565188800_euab065-B25 article-title: Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation publication-title: N Engl J Med doi: 10.1056/NEJMoa1915152 – volume: 168 start-page: 303 year: 2014 ident: 2025052700565188800_euab065-B455 article-title: Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial publication-title: Am Heart J doi: 10.1016/j.ahj.2014.06.005 – volume: 118 start-page: 1668 year: 2018 ident: 2025052700565188800_euab065-B468 article-title: Apixaban versus dalteparin for the treatment of acute venous thromboembolism in patients with cancer: the Caravaggio study publication-title: Thromb Haemost doi: 10.1055/s-0038-1668523 – volume: 5 start-page: e003932 year: 2016 ident: 2025052700565188800_euab065-B359 article-title: Atrial fibrillation patients treated with long-term warfarin anticoagulation have higher rates of all dementia types compared with patients receiving long-term warfarin for other indications publication-title: JAHA doi: 10.1161/JAHA.116.003932 – volume: 9 start-page: 19 year: 2017 ident: 2025052700565188800_euab065-B524 article-title: The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects publication-title: Clin Pharmacol – volume: 176 start-page: 1662 year: 2016 ident: 2025052700565188800_euab065-B319 article-title: Stroke, bleeding, and mortality risks in elderly medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2016.5954 – volume: 310 start-page: 2050 year: 2013 ident: 2025052700565188800_euab065-B370 article-title: Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial publication-title: Jama doi: 10.1001/jama.2013.280521 – volume: 106 start-page: 565 year: 2017 ident: 2025052700565188800_euab065-B414 article-title: The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review publication-title: Clin Res Cardiol doi: 10.1007/s00392-017-1102-5 – volume: 43 start-page: 265 year: 2012 ident: 2025052700565188800_euab065-B221 article-title: Left atrial catheter ablation and ischemic stroke publication-title: Stroke doi: 10.1161/STROKEAHA.111.627067 – volume: 178 start-page: 126 year: 2016 ident: 2025052700565188800_euab065-B270 article-title: Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF) publication-title: Am Heart J doi: 10.1016/j.ahj.2016.05.007 – volume: 45 start-page: 2372 year: 2014 ident: 2025052700565188800_euab065-B282 article-title: Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 publication-title: Stroke doi: 10.1161/STROKEAHA.114.006025 – volume: 134 start-page: 589 year: 2016 ident: 2025052700565188800_euab065-B18 article-title: Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy) publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.020950 – volume: 131 start-page: 269 year: 2018 ident: 2025052700565188800_euab065-B345 article-title: Clinical outcomes and history of fall in patients with atrial fibrillation treated with oral anticoagulation: insights from the ARISTOTLE trial publication-title: Am J Med doi: 10.1016/j.amjmed.2017.10.036 – volume: 121 start-page: 1534 year: 2018 ident: 2025052700565188800_euab065-B276 article-title: Feasibility of left atrial appendage occlusion for left atrial appendage thrombus in patients with persistent atrial fibrillation publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2018.02.045 – volume: 6 start-page: 1546 year: 2019 ident: 2025052700565188800_euab065-B336 article-title: Microbleed prevalence and burden in anticoagulant-associated intracerebral bleed publication-title: Ann Clin Transl Neurol doi: 10.1002/acn3.50834 – volume: 127 start-page: 176 year: 2020 ident: 2025052700565188800_euab065-B371 article-title: Non-vitamin K antagonist oral anticoagulant for atrial fibrillation in obese patients publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2020.04.016 – volume: 40 start-page: 1571 year: 2019 ident: 2025052700565188800_euab065-B436 article-title: Drug-drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy780 – volume: 8 start-page: 202 year: 2010 ident: 2025052700565188800_euab065-B177 article-title: Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2009.03678.x – volume: 75 start-page: 273 year: 2020 ident: 2025052700565188800_euab065-B134 article-title: Oral anticoagulation for patients with atrial fibrillation on long-term hemodialysis publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2019.10.059 – volume: 138 start-page: 37 year: 2018 ident: 2025052700565188800_euab065-B325 article-title: Oral anticoagulation in very elderly patients with atrial fibrillation: a nationwide cohort study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.031658 – volume: 6 start-page: 340 year: 2017 ident: 2025052700565188800_euab065-B451 article-title: Population pharmacokinetics, pharmacodynamics, and exploratory exposure-response analyses of apixaban in subjects treated for venous thromboembolism publication-title: CPT Pharmacometrics Syst Pharmacol doi: 10.1002/psp4.12184 – volume: 105 start-page: 245 year: 2011 ident: 2025052700565188800_euab065-B507 article-title: Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials publication-title: Thromb Haemost doi: 10.1160/TH10-08-0552 – volume: 383 start-page: 1735 year: 2020 ident: 2025052700565188800_euab065-B102 article-title: Low-dose edoxaban in very elderly patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa2012883 – volume: 50 start-page: e344 year: 2019 ident: 2025052700565188800_euab065-B288 article-title: Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 Guidelines for the early management of acute ischemic stroke: a guideline for Healthcare Professionals From the American Heart Association/American Stroke Association publication-title: Stroke doi: 10.1161/STR.0000000000000211 – volume: 320 start-page: 2221 year: 2018 ident: 2025052700565188800_euab065-B80 article-title: Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding publication-title: JAMA doi: 10.1001/jama.2018.17242 – volume: 79 start-page: 1486 year: 2015 ident: 2025052700565188800_euab065-B137 article-title: Short-term safety and plasma concentrations of edoxaban in Japanese patients with non-valvular atrial fibrillation and severe renal impairment publication-title: Circ J doi: 10.1253/circj.CJ-14-0942 – volume: 30 start-page: 421 year: 2014 ident: 2025052700565188800_euab065-B351 article-title: Dementia and cognitive impairment: epidemiology, diagnosis, and treatment publication-title: Clin Geriatr Med doi: 10.1016/j.cger.2014.04.001 – volume: 40 start-page: 2313 year: 2019 ident: 2025052700565188800_euab065-B355 article-title: Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz386 – volume: 35 start-page: 3377 year: 2014 ident: 2025052700565188800_euab065-B19 article-title: Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu305 – volume: 76 start-page: 1192 year: 2019 ident: 2025052700565188800_euab065-B295 article-title: Clinical effectiveness of direct oral anticoagulants vs warfarin in older patients with atrial fibrillation and ischemic stroke: findings from the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2019.2099 – ident: 2025052700565188800_euab065-B472 – volume: 64 start-page: 2471 year: 2014 ident: 2025052700565188800_euab065-B130 article-title: Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.09.051 – volume: 141 start-page: 1384 year: 2020 ident: 2025052700565188800_euab065-B123 article-title: Apixaban versus warfarin in patients with atrial fibrillation and advanced chronic kidney disease publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.119.044059 – volume: 124 start-page: 1573 year: 2011 ident: 2025052700565188800_euab065-B192 article-title: Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.029017 – volume: 41 start-page: 407 year: 2020 ident: 2025052700565188800_euab065-B243 article-title: 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz425 – volume: 53 start-page: 34 year: 2018 ident: 2025052700565188800_euab065-B242 article-title: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS publication-title: Eur J Cardiothorac Surg doi: 10.1093/ejcts/ezx334 – volume: 73 start-page: 919 year: 2019 ident: 2025052700565188800_euab065-B413 article-title: Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and low body weight publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.11.051 – volume: 72 start-page: 1466 year: 2018 ident: 2025052700565188800_euab065-B465 article-title: Edoxaban versus warfarin in Latin American patients with atrial fibrillation: the ENGAGE AF-TIMI 48 trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.07.037 – volume: 76 start-page: 1808 year: 2020 ident: 2025052700565188800_euab065-B43 article-title: Impacts of different renal function estimation formulas on dosing of DOACs and clinical outcomes publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.08.025 – volume: 107 start-page: 985 year: 2012 ident: 2025052700565188800_euab065-B149 article-title: Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate publication-title: Thromb Haemost doi: 10.1160/TH11-11-0804 – volume: 129 start-page: 850 year: 2016 ident: 2025052700565188800_euab065-B168 article-title: Mortality in patients with atrial fibrillation randomized to edoxaban or warfarin: insights from the ENGAGE AF-TIMI 48 trial publication-title: Am J Med doi: 10.1016/j.amjmed.2016.02.028 – volume: 76 start-page: 1111 year: 2020 ident: 2025052700565188800_euab065-B163 article-title: Clinical implications of assessment of apixaban levels in elderly atrial fibrillation patients: J-ELD AF registry sub-cohort analysis publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-020-02896-y – volume: 47 start-page: 105 year: 2017 ident: 2025052700565188800_euab065-B419 article-title: Incidence of seizures following initial ischemic stroke in a community-based cohort: the Framingham Heart Study publication-title: Seizure doi: 10.1016/j.seizure.2017.03.009 – volume: 361 start-page: 2342 year: 2009 ident: 2025052700565188800_euab065-B499 article-title: Dabigatran versus warfarin in the treatment of acute venous thromboembolism publication-title: N Engl J Med doi: 10.1056/NEJMoa0906598 – volume: 22 start-page: 361 year: 2020 ident: 2025052700565188800_euab065-B392 article-title: Impact of weight on the efficacy and safety of direct-acting oral anticoagulants in patients with non-valvular atrial fibrillation: a meta-analysis publication-title: Europace doi: 10.1093/europace/euz361 – volume: 248 start-page: 232 year: 2017 ident: 2025052700565188800_euab065-B34 article-title: Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2017.08.010 – volume: 358 start-page: 273 year: 2019 ident: 2025052700565188800_euab065-B275 article-title: Outcome of anticoagulation therapy of left atrial thrombus or sludge in patients with nonvalvular atrial fibrillation or flutter publication-title: Am J Med Sci doi: 10.1016/j.amjms.2019.07.013 – volume: 49 start-page: 121 year: 2020 ident: 2025052700565188800_euab065-B201 article-title: Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-019-01973-z – volume: 140 start-page: 1921 year: 2019 ident: 2025052700565188800_euab065-B248 article-title: Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated medically or with percutaneous coronary intervention or undergoing elective percutaneous coronary intervention: insights from the AUGUSTUS Trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.119.043308 – volume: 54 start-page: 917 year: 2014 ident: 2025052700565188800_euab065-B551 article-title: Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF publication-title: J Clin Pharmacol doi: 10.1002/jcph.288 – volume: 111 start-page: 933 year: 2014 ident: 2025052700565188800_euab065-B99 article-title: Patient outcomes using the European label for dabigatran. A post-hoc analysis from the RE-LY database publication-title: Thromb Haemost – volume: 67 start-page: 3020 year: 2016 ident: 2025052700565188800_euab065-B33 article-title: Stroke and bleeding risks in NOAC- and warfarin-treated patients with hypertrophic cardiomyopathy and atrial fibrillation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.04.026 – volume: 385 start-page: 2288 year: 2015 ident: 2025052700565188800_euab065-B98 article-title: Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial publication-title: Lancet doi: 10.1016/S0140-6736(14)61943-7 – volume: 37 start-page: 2869 year: 2016 ident: 2025052700565188800_euab065-B388 article-title: The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw124 – volume: 31 start-page: 193 year: 2017 ident: 2025052700565188800_euab065-B545 article-title: Old and new oral anticoagulants: food, herbal medicines and drug interactions publication-title: Blood Rev doi: 10.1016/j.blre.2017.02.001 – volume: 22 start-page: 983 year: 1991 ident: 2025052700565188800_euab065-B312 article-title: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study publication-title: Stroke doi: 10.1161/01.STR.22.8.983 – volume: 382 start-page: 120 year: 2020 ident: 2025052700565188800_euab065-B30 article-title: A controlled trial of rivaroxaban after transcatheter aortic-valve replacement publication-title: N Engl J Med doi: 10.1056/NEJMoa1911425 – volume: 159 start-page: 1102 year: 2010 ident: 2025052700565188800_euab065-B119 article-title: Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC) publication-title: Am Heart J doi: 10.1016/j.ahj.2010.03.027 – volume: 131 start-page: 82 year: 2015 ident: 2025052700565188800_euab065-B191 article-title: Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.013445 – volume: 168 start-page: 237 year: 2018 ident: 2025052700565188800_euab065-B217 article-title: Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery publication-title: Ann Intern Med doi: 10.7326/M17-2341 – volume: 37 start-page: 267 year: 2016 ident: 2025052700565188800_euab065-B265 article-title: 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv320 – volume: 228 start-page: 771 year: 2017 ident: 2025052700565188800_euab065-B412 article-title: Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2016.11.277 – volume: 72 start-page: 838 year: 2018 ident: 2025052700565188800_euab065-B457 article-title: Edoxaban in Asian patients with atrial fibrillation: effectiveness and safety publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.05.066 – volume: 104 start-page: 1191 year: 2018 ident: 2025052700565188800_euab065-B542 article-title: Cytochrome P450 3A induction predicts P-glycoprotein Induction; Part 2: prediction of decreased substrate exposure after rifabutin or carbamazepine publication-title: Clin Pharmacol Ther doi: 10.1002/cpt.1072 – volume: 31 start-page: e24 year: 2017 ident: 2025052700565188800_euab065-B234 article-title: Impact of the direct oral anticoagulants on activated clotting time publication-title: J Cardiothorac Vasc Anesth doi: 10.1053/j.jvca.2016.09.002 – volume: 82 start-page: 1591 year: 2016 ident: 2025052700565188800_euab065-B531 article-title: Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.13092 – volume: 292 start-page: 2471 year: 2004 ident: 2025052700565188800_euab065-B366 article-title: Obesity and the risk of new-onset atrial fibrillation publication-title: JAMA doi: 10.1001/jama.292.20.2471 – volume: 50 start-page: 743 year: 2010 ident: 2025052700565188800_euab065-B518 article-title: Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers publication-title: J Clin Pharmacol doi: 10.1177/0091270009351883 – volume: 119 start-page: 1989 year: 2017 ident: 2025052700565188800_euab065-B390 article-title: Relation of risk of stroke in patients with atrial fibrillation to body mass index (from patients treated with rivaroxaban and warfarin in the rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation trial publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2017.03.028 – volume: 53 start-page: 2523 year: 2014 ident: 2025052700565188800_euab065-B477 article-title: Acute thrombocytopenia after initiating anticoagulation with rivaroxaban publication-title: Intern Med doi: 10.2169/internalmedicine.53.2890 – volume: 135 start-page: 491 year: 2020 ident: 2025052700565188800_euab065-B41 article-title: Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children publication-title: Blood doi: 10.1182/blood.2019000998 – volume: 382 start-page: 1208 year: 2020 ident: 2025052700565188800_euab065-B261 article-title: Polymer-based or polymer-free stents in patients at high bleeding risk publication-title: N Engl J Med doi: 10.1056/NEJMoa1910021 – volume: 139 start-page: 2292 year: 2019 ident: 2025052700565188800_euab065-B389 article-title: Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and extremes in body weight publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.037955 – volume: 376 start-page: 1627 year: 2017 ident: 2025052700565188800_euab065-B224 article-title: Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1701005 – volume: 47 start-page: 512 year: 2019 ident: 2025052700565188800_euab065-B469 article-title: Effectiveness and safety of non-vitamin-K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with thrombocytopenia publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-018-1792-1 – volume: 20 start-page: 705 year: 2009 ident: 2025052700565188800_euab065-B121 article-title: Dilemmas in the management of atrial fibrillation in chronic kidney disease publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2007111207 – volume: 49 start-page: 2122 year: 2018 ident: 2025052700565188800_euab065-B53 article-title: Improved stroke prevention in atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants publication-title: Stroke doi: 10.1161/STROKEAHA.118.021990 – volume: 329 start-page: 673 year: 1993 ident: 2025052700565188800_euab065-B173 article-title: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJM199309023291001 – volume: 43 start-page: 1812 year: 2012 ident: 2025052700565188800_euab065-B176 article-title: Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal publication-title: Stroke doi: 10.1161/STROKEAHA.112.652065 – volume: 56 start-page: M146 year: 2001 ident: 2025052700565188800_euab065-B337 article-title: Frailty in older adults: evidence for a phenotype publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/56.3.M146 – volume: 107 start-page: 925 year: 2012 ident: 2025052700565188800_euab065-B521 article-title: Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation publication-title: Thromb Haemost doi: 10.1160/TH11-08-0566 – volume: 66 start-page: 91 year: 2015 ident: 2025052700565188800_euab065-B138 article-title: Dose-finding study of rivaroxaban in hemodialysis patients publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2015.01.022 – volume: 372 start-page: 1791 year: 2015 ident: 2025052700565188800_euab065-B264 article-title: Long-term use of ticagrelor in patients with prior myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJMoa1500857 – volume: 36 start-page: 2239 year: 2015 ident: 2025052700565188800_euab065-B522 article-title: Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv201 – volume: 51 start-page: 687 year: 2011 ident: 2025052700565188800_euab065-B108 article-title: Effects of food on the pharmacokinetics of edoxaban, an oral direct factor Xa inhibitor, in healthy volunteers publication-title: J Clin Pharmacol doi: 10.1177/0091270010370974 – volume: 381 start-page: 1103 year: 2019 ident: 2025052700565188800_euab065-B259 article-title: Antithrombotic therapy for atrial fibrillation with stable coronary disease publication-title: N Engl J Med doi: 10.1056/NEJMoa1904143 – volume: 123 start-page: 63 year: 2019 ident: 2025052700565188800_euab065-B274 article-title: Prevalence and resolution of left atrial thrombus in patients with nonvalvular atrial fibrillation and flutter with oral anticoagulation publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2018.09.027 – volume: 64 start-page: 292 year: 2007 ident: 2025052700565188800_euab065-B376 article-title: The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2007.02899.x – volume: 358 start-page: 2776 year: 2008 ident: 2025052700565188800_euab065-B514 article-title: Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty publication-title: N Engl J Med doi: 10.1056/NEJMoa076016 – volume: 37 start-page: 1070 year: 2006 ident: 2025052700565188800_euab065-B443 article-title: Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation publication-title: Stroke doi: 10.1161/01.STR.0000208294.46968.a4 – volume: 663 start-page: 229 year: 2010 ident: 2025052700565188800_euab065-B546 article-title: Antithrombotic effects of naturally derived products on coagulation and platelet function publication-title: Methods Mol Biol doi: 10.1007/978-1-60761-803-4_9 – volume: 85 start-page: 823 year: 2019 ident: 2025052700565188800_euab065-B292 article-title: Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation publication-title: Ann Neurol doi: 10.1002/ana.25489 – volume: 39 start-page: 2942 year: 2018 ident: 2025052700565188800_euab065-B223 article-title: Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy176 – volume: 377 start-page: 431 year: 2017 ident: 2025052700565188800_euab065-B181 article-title: Idarucizumab for dabigatran reversal—full cohort analysis publication-title: N Engl J Med doi: 10.1056/NEJMoa1707278 – volume: 165 start-page: 355 year: 2013 ident: 2025052700565188800_euab065-B485 article-title: Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2012.08.036 – volume: 14 start-page: e0213379 year: 2019 ident: 2025052700565188800_euab065-B279 article-title: Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants—a systematic review publication-title: PloS One doi: 10.1371/journal.pone.0213379 – volume: 19 start-page: 247 year: 2019 ident: 2025052700565188800_euab065-B364 article-title: TV-based assistive integrated service to support European adults living with mild dementia or mild cognitive impairment (TV-AssistDem): study protocol for a multicentre randomized controlled trial publication-title: BMC Geriatr doi: 10.1186/s12877-019-1267-z – volume: 129 start-page: 2980 year: 2017 ident: 2025052700565188800_euab065-B283 article-title: Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy publication-title: Blood doi: 10.1182/blood-2016-08-731638 – volume: 119 start-page: 2172 year: 2012 ident: 2025052700565188800_euab065-B202 article-title: Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding publication-title: Blood doi: 10.1182/blood-2011-11-393587 – volume: 57 start-page: 221 year: 2018 ident: 2025052700565188800_euab065-B111 article-title: An open-label crossover study of the pharmacokinetics of the 60-mg edoxaban tablet crushed and administered either by a nasogastric tube or in apple puree in healthy adults publication-title: Clin Pharmacokinet doi: 10.1007/s40262-017-0554-0 – volume: 3 start-page: e228 year: 2016 ident: 2025052700565188800_euab065-B505 article-title: Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study publication-title: Lancet Haematol doi: 10.1016/S2352-3026(16)00023-5 – volume: 83 start-page: 186 year: 2018 ident: 2025052700565188800_euab065-B200 article-title: Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage publication-title: Ann Neurol doi: 10.1002/ana.25134 – volume: 58 start-page: 581 year: 2011 ident: 2025052700565188800_euab065-B538 article-title: Effect of multiple doses of omeprazole on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban publication-title: J Cardiovasc Pharmacol doi: 10.1097/FJC.0b013e31822f6c2b – volume: 118 start-page: 842 year: 2018 ident: 2025052700565188800_euab065-B197 article-title: Prothrombin complex concentrate for major bleeding on factor Xa inhibitors: a prospective cohort study publication-title: Thromb Haemost doi: 10.1055/s-0038-1636541 – volume: 80 start-page: 46 year: 2020 ident: 2025052700565188800_euab065-B430 article-title: Clinically relevant interaction of rivaroxaban and valproic acid—a case report publication-title: Seizure doi: 10.1016/j.seizure.2020.05.024 – volume: 369 start-page: 1406 year: 2013 ident: 2025052700565188800_euab065-B500 article-title: Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism publication-title: N Engl J Med doi: 10.1056/NEJMoa1306638 – volume: 106 start-page: 303 year: 2013 ident: 2025052700565188800_euab065-B340 article-title: Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people publication-title: Arch Cardiovasc Dis doi: 10.1016/j.acvd.2013.04.001 – volume: 120 start-page: 573 year: 2017 ident: 2025052700565188800_euab065-B361 article-title: Vascular cognitive impairment publication-title: Circ Res doi: 10.1161/CIRCRESAHA.116.308426 – volume: 116 start-page: 94 year: 2012 ident: 2025052700565188800_euab065-B190 article-title: Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model publication-title: Anesthesiology doi: 10.1097/ALN.0b013e318238c036 – volume: 88 start-page: 56 year: 2020 ident: 2025052700565188800_euab065-B304 article-title: Genetically elevated LDL associates with lower risk of intracerebral hemorrhage publication-title: Ann Neurol doi: 10.1002/ana.25740 – volume: 372 start-page: 31 year: 2008 ident: 2025052700565188800_euab065-B513 article-title: Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(08)60880-6 – volume: 37 start-page: 539 year: 2020 ident: 2025052700565188800_euab065-B328 article-title: A structured literature review and international consensus validation of FORTA labels of oral anticoagulants for long-term treatment of atrial fibrillation in older patients (OAC-FORTA 2019) publication-title: Drugs Aging doi: 10.1007/s40266-020-00771-0 – ident: 2025052700565188800_euab065-B403 – volume: 38 start-page: 852 year: 2017 ident: 2025052700565188800_euab065-B86 article-title: Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1 publication-title: Eur Heart J – ident: 2025052700565188800_euab065-B365 – volume: 50 start-page: 873 year: 2019 ident: 2025052700565188800_euab065-B277 article-title: Cerebral ischemia in patients on direct oral anticoagulants publication-title: Stroke doi: 10.1161/STROKEAHA.118.023877 – volume: 40 start-page: 3802 year: 2019 ident: 2025052700565188800_euab065-B437 article-title: Strategies in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants (NOACs) and co-medications with possible drug-drug interaction publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz659 – volume: 69 start-page: 1363 year: 2017 ident: 2025052700565188800_euab065-B22 article-title: Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.12.038 – volume: 130 start-page: 517 year: 2017 ident: 2025052700565188800_euab065-B395 article-title: Oral anticoagulant use after bariatric surgery: a literature review and clinical guidance publication-title: Am J Med doi: 10.1016/j.amjmed.2016.12.033 – volume: 63 start-page: 469 year: 2007 ident: 2025052700565188800_euab065-B537 article-title: Rivaroxaban (BAY 59-7939)—an oral, direct Factor Xa inhibitor–has no clinically relevant interaction with naproxen publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2006.02776.x – volume: 63 start-page: 321 year: 2014 ident: 2025052700565188800_euab065-B97 article-title: The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy) publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.07.104 – volume: 125 start-page: 417 year: 2012 ident: 2025052700565188800_euab065-B150 article-title: Interpretation of point-of-care INR results in patients treated with dabigatran publication-title: Am J Med doi: 10.1016/j.amjmed.2011.10.017 – volume: 124 start-page: 879 year: 2019 ident: 2025052700565188800_euab065-B258 article-title: Meta-analysis of oral anticoagulant monotherapy as an antithrombotic strategy in patients with stable coronary artery disease and nonvalvular atrial fibrillation publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2019.05.072 – volume: 7 start-page: e008987 year: 2018 ident: 2025052700565188800_euab065-B489 article-title: Efficacy and safety of edoxaban in patients with active malignancy and atrial fibrillation: analysis of the ENGAGE AF-TIMI 48 trial publication-title: J Am Heart Assoc doi: 10.1161/JAHA.118.008987 – volume: 338 start-page: 372 year: 2011 ident: 2025052700565188800_euab065-B93 article-title: In vitro and in vivo P-glycoprotein transport characteristics of rivaroxaban publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.111.180240 – volume: 315 start-page: 1582 year: 1997 ident: 2025052700565188800_euab065-B416 article-title: Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project publication-title: BMJ doi: 10.1136/bmj.315.7122.1582 – volume: 158 start-page: 629 year: 2009 ident: 2025052700565188800_euab065-B120 article-title: Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study publication-title: Am Heart J doi: 10.1016/j.ahj.2009.06.031 – volume: 81 start-page: 843 year: 2016 ident: 2025052700565188800_euab065-B348 article-title: Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage: a TQIP study publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0000000000001245 – volume: 130 start-page: 1706 year: 2017 ident: 2025052700565188800_euab065-B196 article-title: Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study publication-title: Blood doi: 10.1182/blood-2017-05-782060 – volume: 17 start-page: 539 year: 2018 ident: 2025052700565188800_euab065-B294 article-title: Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(18)30145-5 – volume: 365 start-page: 883 year: 2011 ident: 2025052700565188800_euab065-B46 article-title: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1009638 – volume: 61 start-page: e01201 year: 2017 ident: 2025052700565188800_euab065-B533 article-title: Differential influence of the antiretroviral pharmacokinetic enhancers ritonavir and cobicistat on intestinal P-glycoprotein transport and the pharmacokinetic/pharmacodynamic disposition of dabigatran publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01201-17 – volume: 25 start-page: 55 year: 2020 ident: 2025052700565188800_euab065-B306 article-title: Net clinical benefit of anticoagulation for atrial fibrillation following intracerebral hemorrhage publication-title: Vasc Med doi: 10.1177/1358863X19883027 – volume: 9 start-page: 1067 year: 2018 ident: 2025052700565188800_euab065-B541 article-title: Pharmacokinetic interactions of clinical interest between direct oral anticoagulants and antiepileptic drugs publication-title: Front Neurol doi: 10.3389/fneur.2018.01067 – volume: 124 start-page: 955 year: 2014 ident: 2025052700565188800_euab065-B186 article-title: Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry publication-title: Blood doi: 10.1182/blood-2014-03-563577 – volume: 205 start-page: 63 year: 2018 ident: 2025052700565188800_euab065-B29 article-title: Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial publication-title: Am Heart J doi: 10.1016/j.ahj.2018.07.006 – volume: 159 start-page: 677 year: 1999 ident: 2025052700565188800_euab065-B344 article-title: Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls publication-title: Arch Intern Med doi: 10.1001/archinte.159.7.677 – volume: 6 start-page: 451 year: 2013 ident: 2025052700565188800_euab065-B38 article-title: Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.112.000143 – volume: 133 start-page: 1540 year: 2016 ident: 2025052700565188800_euab065-B298 article-title: Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.019794 – volume: 366 start-page: 1287 year: 2012 ident: 2025052700565188800_euab065-B502 article-title: Oral rivaroxaban for the treatment of symptomatic pulmonary embolism publication-title: N Engl J Med doi: 10.1056/NEJMoa1113572 – volume: 382 start-page: 1599 year: 2020 ident: 2025052700565188800_euab065-B486 article-title: Apixaban for the treatment of venous thromboembolism associated with cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1915103 – volume: 394 start-page: 1335 year: 2019 ident: 2025052700565188800_euab065-B245 article-title: Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial publication-title: Lancet doi: 10.1016/S0140-6736(19)31872-0 – volume: 12 start-page: 1162 year: 2015 ident: 2025052700565188800_euab065-B233 article-title: Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2015.02.028 – volume: 127 start-page: 634 year: 2013 ident: 2025052700565188800_euab065-B114 article-title: Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.115386 – volume: 34 start-page: e26 year: 2014 ident: 2025052700565188800_euab065-B399 article-title: Warfarin dosing changes after bariatric surgery: implications on the mechanism for altered dose requirements and safety concerns–an alternative viewpoint publication-title: Pharmacotherapy doi: 10.1002/phar.1417 – volume: 331 start-page: 821 year: 1994 ident: 2025052700565188800_euab065-B350 article-title: A multifactorial intervention to reduce the risk of falling among elderly people living in the community publication-title: N Engl J Med doi: 10.1056/NEJM199409293311301 – volume: 375 start-page: 1131 year: 2016 ident: 2025052700565188800_euab065-B179 article-title: Andexanet alfa for acute major bleeding associated with factor Xa inhibitors publication-title: N Engl J Med doi: 10.1056/NEJMoa1607887 – volume: 37 start-page: 1075 year: 2006 ident: 2025052700565188800_euab065-B343 article-title: Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation publication-title: Stroke doi: 10.1161/01.STR.0000209239.71702.ce – volume: 200 start-page: 44 year: 2018 ident: 2025052700565188800_euab065-B28 article-title: Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: the randomized ATLANTIS trial publication-title: Am Heart J doi: 10.1016/j.ahj.2018.03.008 – volume: 45 start-page: 543 year: 2018 ident: 2025052700565188800_euab065-B104 article-title: Direct-acting oral anticoagulant drug level monitoring in clinical patient management publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-018-1643-0 – volume: 8 start-page: e011358 year: 2019 ident: 2025052700565188800_euab065-B357 article-title: Nonvitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study publication-title: J Am Heart Assoc doi: 10.1161/JAHA.118.011358 – volume: 136 start-page: 1074 year: 2015 ident: 2025052700565188800_euab065-B83 article-title: Gastrointestinal bleeding in patients receiving oral anticoagulation: current treatment and pharmacological perspectives publication-title: Thromb Res doi: 10.1016/j.thromres.2015.10.016 – volume: 105 start-page: 721 year: 2011 ident: 2025052700565188800_euab065-B508 article-title: Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II). A randomised, double-blind, non-inferiority trial publication-title: Thromb Haemost doi: 10.1160/TH10-10-0679 – volume: 368 start-page: 709 year: 2013 ident: 2025052700565188800_euab065-B504 article-title: Extended use of dabigatran, warfarin, or placebo in venous thromboembolism publication-title: N Engl J Med doi: 10.1056/NEJMoa1113697 – volume: 27 start-page: 1338 year: 2018 ident: 2025052700565188800_euab065-B169 article-title: Characteristics of symptomatic intracerebral hemorrhage in patient receiving direct oral anticoagulants: comparison with warfarin publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2017.12.020 – volume: 9 start-page: 2168 year: 2011 ident: 2025052700565188800_euab065-B375 article-title: Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2011.04498.x – volume: 149 start-page: 315 year: 2016 ident: 2025052700565188800_euab065-B471 article-title: Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report publication-title: Chest doi: 10.1016/j.chest.2015.11.026 – volume: 5 start-page: 145 year: 2019 ident: 2025052700565188800_euab065-B488 article-title: Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF publication-title: Eur Heart J Qual Care Clin Outcomes doi: 10.1093/ehjqcco/qcy040 – volume: 13 start-page: 2587 year: 2020 ident: 2025052700565188800_euab065-B27 article-title: Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after TAVR publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2020.09.013 – volume: 107 start-page: 838 year: 2012 ident: 2025052700565188800_euab065-B205 article-title: Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice publication-title: Thromb Haemost doi: 10.1160/TH11-10-0718 – year: 2020 ident: 2025052700565188800_euab065-B320 article-title: Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: one year follow up of the prospective observational ETNA-AF-Europe study publication-title: Eur Heart J Cardiovasc Pharmacother – volume: 19 start-page: 1757 year: 2017 ident: 2025052700565188800_euab065-B12 article-title: Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE publication-title: Europace doi: 10.1093/europace/eux240 – volume: 18 start-page: 955 year: 2016 ident: 2025052700565188800_euab065-B180 article-title: Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants publication-title: Europace doi: 10.1093/europace/euv030 – volume: 90 start-page: e1143 year: 2018 ident: 2025052700565188800_euab065-B286 article-title: Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin publication-title: Neurology doi: 10.1212/WNL.0000000000005207 – volume: 369 start-page: 799 year: 2013 ident: 2025052700565188800_euab065-B498 article-title: Oral apixaban for the treatment of acute venous thromboembolism publication-title: N Engl J Med doi: 10.1056/NEJMoa1302507 – volume: 38 start-page: 1023 year: 2018 ident: 2025052700565188800_euab065-B126 article-title: Safety of edoxaban 30 mg in elderly patients with severe renal impairment publication-title: Clin Drug Investig doi: 10.1007/s40261-018-0693-6 – volume: 53 start-page: 165 year: 2019 ident: 2025052700565188800_euab065-B393 article-title: Comparing the efficacy and safety of direct oral anticoagulants with warfarin in the morbidly obese population with atrial fibrillation publication-title: Ann Pharmacother doi: 10.1177/1060028018796604 – volume: 48 start-page: 1 year: 2009 ident: 2025052700565188800_euab065-B396 article-title: Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development publication-title: Clin Pharmacokinet doi: 10.2165/0003088-200948010-00001 – volume: 7 start-page: 2543 year: 2019 ident: 2025052700565188800_euab065-B479 article-title: Thrombocytopenia: a possible side effect of apixaban publication-title: Clin Case Rep doi: 10.1002/ccr3.2532 – volume: 89 start-page: 680 year: 2018 ident: 2025052700565188800_euab065-B335 article-title: Correlation of non-vitamin K antagonist oral anticoagulant exposure and cerebral microbleeds in Chinese patients with atrial fibrillation publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2017-317151 – volume: 39 start-page: 119 year: 2018 ident: 2025052700565188800_euab065-B76 article-title: 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx393 – volume: 10 start-page: 1841 year: 2012 ident: 2025052700565188800_euab065-B189 article-title: Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2012.04859.x – volume: 130 start-page: 1440 year: 2017 ident: 2025052700565188800_euab065-B490 article-title: Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and a history of cancer: insights from the ARISTOTLE trial publication-title: Am J Med doi: 10.1016/j.amjmed.2017.06.026 – volume: 3 start-page: e203593 year: 2020 ident: 2025052700565188800_euab065-B528 article-title: Association of oral anticoagulants and verapamil or diltiazem with adverse bleeding events in patients with nonvalvular atrial fibrillation and normal kidney function publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2020.3593 – volume: 142 start-page: 39 year: 2019 ident: 2025052700565188800_euab065-B113 article-title: Safety of apixaban administered via nasogastric tube publication-title: Cardiology doi: 10.1159/000495577 – volume: 20 start-page: 1399 year: 2018 ident: 2025052700565188800_euab065-B352 article-title: European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? publication-title: Europace doi: 10.1093/europace/euy046 – volume: 123 start-page: 2363 year: 2011 ident: 2025052700565188800_euab065-B170 article-title: Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.004747 – volume: 48 start-page: 406 year: 2018 ident: 2025052700565188800_euab065-B492 article-title: Effect of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with newly diagnosed cancer publication-title: Korean Circ J doi: 10.4070/kcj.2017.0328 – volume: 50 start-page: 675 year: 2011 ident: 2025052700565188800_euab065-B377 article-title: Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention publication-title: Clin Pharmacokinet doi: 10.2165/11595320-000000000-00000 – volume: 50 start-page: 1364 year: 2019 ident: 2025052700565188800_euab065-B239 article-title: Perioperative/postoperative atrial fibrillation and risk of subsequent stroke and/or mortality publication-title: Stroke doi: 10.1161/STROKEAHA.118.023921 – volume: 48 start-page: 3040 year: 2017 ident: 2025052700565188800_euab065-B456 article-title: Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation publication-title: Stroke doi: 10.1161/STROKEAHA.117.018773 – volume: 377 start-page: 1513 year: 2017 ident: 2025052700565188800_euab065-B247 article-title: Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1708454 – volume: 140 start-page: e125 year: 2019 ident: 2025052700565188800_euab065-B2 article-title: 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons publication-title: Circulation doi: 10.1161/CIR.0000000000000665 – volume: 5 start-page: e000800 year: 2018 ident: 2025052700565188800_euab065-B463 article-title: Efficacy and safety of dabigatran versus warfarin from the RE-LY trial publication-title: Open Heart doi: 10.1136/openhrt-2018-000800 – ident: 2025052700565188800_euab065-B347 article-title: Antithrombotic agents and traumatic brain injury in the elderly population: hemorrhage patterns and outcomes publication-title: J Neurosurg – volume: 24 start-page: 2757 year: 2008 ident: 2025052700565188800_euab065-B204 article-title: Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects publication-title: Curr Med Res Opin doi: 10.1185/03007990802361499 – volume: 380 start-page: 1326 year: 2019 ident: 2025052700565188800_euab065-B185 article-title: Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors publication-title: N Engl J Med doi: 10.1056/NEJMoa1814051 – volume: 27 start-page: e584 year: 2020 ident: 2025052700565188800_euab065-B267 article-title: Use of direct oral anticoagulants in the treatment of left ventricular thrombus: systematic review of current literature publication-title: Am J Ther doi: 10.1097/MJT.0000000000000937 – volume: 41 start-page: 855 year: 2018 ident: 2025052700565188800_euab065-B74 article-title: Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis publication-title: Clin Cardiol doi: 10.1002/clc.22971 – volume: 46 start-page: 702 year: 2006 ident: 2025052700565188800_euab065-B525 article-title: No interaction between the novel, oral direct factor Xa inhibitor BAY 59-7939 and digoxin publication-title: J Clin Pharmacol – volume: 8 start-page: e022690 year: 2018 ident: 2025052700565188800_euab065-B144 article-title: Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study publication-title: BMJ Open doi: 10.1136/bmjopen-2018-022690 – volume: 3 start-page: 42 year: 2017 ident: 2025052700565188800_euab065-B152 article-title: Non-vitamin-K oral anticoagulants and laboratory testing: now and in the future: views from a workshop at the European Medicines Agency (EMA) publication-title: Eur Heart J Cardiovasc Pharmacother doi: 10.1093/ehjcvp/pvw032 – start-page: e005835 year: 2017 ident: 2025052700565188800_euab065-B21 article-title: Effects of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease: a systematic review and meta-analysis – volume: 223 start-page: 3 year: 2020 ident: 2025052700565188800_euab065-B124 article-title: Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease publication-title: Am Heart J doi: 10.1016/j.ahj.2020.01.010 – volume: 36 start-page: 297 year: 2015 ident: 2025052700565188800_euab065-B131 article-title: Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu139 – volume: 9 start-page: 59 year: 2009 ident: 2025052700565188800_euab065-B529 article-title: Coadministration of dabigatran etexilate and atorvastatin: assessment of potential impact on pharmacokinetics and pharmacodynamics publication-title: Am J Cardiovasc Drugs doi: 10.1007/BF03256595 – volume: 262 start-page: 85 year: 2018 ident: 2025052700565188800_euab065-B391 article-title: Impact of BMI on clinical outcomes of NOAC therapy in daily care—results of the prospective Dresden NOAC Registry (NCT01588119) publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2018.03.060 – volume: 49 start-page: 1872 year: 2018 ident: 2025052700565188800_euab065-B448 article-title: Age threshold for ischemic stroke risk in atrial fibrillation publication-title: Stroke doi: 10.1161/STROKEAHA.118.021047 – volume: 11 start-page: 748 year: 2016 ident: 2025052700565188800_euab065-B497 article-title: Measuring non-vitamin K antagonist oral anticoagulant levels: when is it appropriate and which methods should be used? publication-title: Int J Stroke doi: 10.1177/1747493016659671 – volume: 12 start-page: 1386 year: 2017 ident: 2025052700565188800_euab065-B117 article-title: eGFR and albuminuria in relation to risk of incident atrial fibrillation: a meta-analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.01860217 – volume: 5 start-page: 685 year: 2020 ident: 2025052700565188800_euab065-B266 article-title: Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2020.0652 – volume: 39 start-page: 2959 year: 2018 ident: 2025052700565188800_euab065-B272 article-title: Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy148 – volume: 36 start-page: e5 year: 2016 ident: 2025052700565188800_euab065-B543 article-title: Reduced anticoagulant effect of dabigatran in a patient receiving concomitant phenytoin publication-title: Pharmacotherapy doi: 10.1002/phar.1698 – volume: 36 start-page: 1805 year: 2015 ident: 2025052700565188800_euab065-B226 article-title: Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv177 – volume: 76 start-page: 455 year: 2013 ident: 2025052700565188800_euab065-B94 article-title: Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.12075 – volume: 19 start-page: 945 year: 2019 ident: 2025052700565188800_euab065-B427 article-title: Timing use of novel anti-epileptic drugs: is earlier better? publication-title: Expert Rev Neurother doi: 10.1080/14737175.2019.1636649 – volume: 72 start-page: 153 year: 2018 ident: 2025052700565188800_euab065-B470 article-title: Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and thrombocytopenia publication-title: J Cardiovasc Pharmacol doi: 10.1097/FJC.0000000000000607 – ident: 2025052700565188800_euab065-B16 article-title: Rivaroxaban versus warfarin in patients with mechanical heart valves: open-label, proof-of-concept trial—the RIWA study doi: 10.1007/s40256-020-00449-3 – volume: 50 start-page: 939 year: 2019 ident: 2025052700565188800_euab065-B300 article-title: Non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with intracerebral hemorrhage publication-title: Stroke doi: 10.1161/STROKEAHA.118.023797 – volume: 131 start-page: 972 year: 2015 ident: 2025052700565188800_euab065-B140 article-title: Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.014113 – volume: 133 start-page: 1195 year: 2020 ident: 2025052700565188800_euab065-B45 article-title: Regular bleeding risk assessment associated with reduction in bleeding outcomes: the mAFA-II randomized trial publication-title: Am J Med doi: 10.1016/j.amjmed.2020.03.019 – volume: 6 start-page: 740 year: 2013 ident: 2025052700565188800_euab065-B37 article-title: Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.113.000212 – volume: 9 start-page: e031341 year: 2019 ident: 2025052700565188800_euab065-B65 article-title: Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK publication-title: BMJ Open doi: 10.1136/bmjopen-2019-031341 – volume: 28 start-page: 90 year: 2019 ident: 2025052700565188800_euab065-B273 article-title: Left Atrial or Left Atrial appendage thrombus resolution after adjustment of oral anticoagulant treatment publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2018.09.015 – volume: 363 start-page: 2499 year: 2010 ident: 2025052700565188800_euab065-B501 article-title: Oral rivaroxaban for symptomatic venous thromboembolism publication-title: N Engl J Med doi: 10.1056/NEJMoa1007903 – volume: 45 start-page: 1304 year: 2014 ident: 2025052700565188800_euab065-B464 article-title: Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation publication-title: Stroke doi: 10.1161/STROKEAHA.113.004506 – volume: 1 start-page: 180 year: 2017 ident: 2025052700565188800_euab065-B380 article-title: The impact of body weight on rivaroxaban pharmacokinetics publication-title: Res Pract Thromb Haemost doi: 10.1002/rth2.12039 – volume: 47 start-page: 47 year: 2008 ident: 2025052700565188800_euab065-B374 article-title: Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects publication-title: Clin Pharmacokinet doi: 10.2165/00003088-200847010-00005 – volume: 383 start-page: 955 year: 2014 ident: 2025052700565188800_euab065-B6 article-title: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(13)62343-0 – volume: 40 start-page: 3800 year: 2019 ident: 2025052700565188800_euab065-B435 article-title: Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz657 – volume: 65 start-page: 896 year: 2010 ident: 2025052700565188800_euab065-B555 article-title: The development and validation of a brief performance-based fall risk assessment tool for use in primary care publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glq067 – volume: 18 start-page: 29 year: 2020 ident: 2025052700565188800_euab065-B268 article-title: Direct oral anticoagulant use in left ventricular thrombus publication-title: Thromb J doi: 10.1186/s12959-020-00242-x – volume: 32 start-page: 1968 year: 2011 ident: 2025052700565188800_euab065-B7 article-title: Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism publication-title: Eur Heart J doi: 10.1093/eurheartj/ehr052 – volume: 43 start-page: 229 year: 2016 ident: 2025052700565188800_euab065-B139 article-title: Pharmacokinetics, pharmacodynamics, and safety of single-dose rivaroxaban in chronic hemodialysis publication-title: Am J Nephrol doi: 10.1159/000445328 – volume: 3 start-page: 321 year: 2014 ident: 2025052700565188800_euab065-B112 article-title: Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube publication-title: Clin Pharmacol Drug Dev doi: 10.1002/cpdd.123 – volume: 3 start-page: e206424 year: 2020 ident: 2025052700565188800_euab065-B301 article-title: Association of ischemic stroke, major bleeding, and other adverse events with warfarin use vs non-vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation with a history of intracranial hemorrhage publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2020.6424 – volume: 155 start-page: 354 year: 2019 ident: 2025052700565188800_euab065-B35 article-title: Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation with hypertrophic cardiomyopathy: a nationwide cohort study publication-title: Chest doi: 10.1016/j.chest.2018.11.009 – volume: 50 start-page: 2582 year: 2019 ident: 2025052700565188800_euab065-B36 article-title: Novel oral anticoagulants for primary stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation publication-title: Stroke doi: 10.1161/STROKEAHA.119.026048 – volume: 3 start-page: 692 year: 2005 ident: 2025052700565188800_euab065-B172 article-title: Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2005.01204.x – volume: 13 start-page: 27 year: 2015 ident: 2025052700565188800_euab065-B511 article-title: Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V publication-title: Thromb J doi: 10.1186/s12959-015-0057-x – volume: 6 start-page: 147 year: 2020 ident: 2025052700565188800_euab065-B433 article-title: Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs publication-title: Eur Heart J Cardiovasc Pharmacother doi: 10.1093/ehjcvp/pvz035 – volume: 31 start-page: 331 year: 2019 ident: 2025052700565188800_euab065-B363 article-title: Determinants of medication adherence in older people with dementia from the caregivers' perspective publication-title: Int Psychogeriatr doi: 10.1017/S1041610218000583 – volume: 130 start-page: 449 year: 2017 ident: 2025052700565188800_euab065-B60 article-title: Absence of oral anticoagulation and subsequent outcomes among outpatients with atrial fibrillation publication-title: Am J Med doi: 10.1016/j.amjmed.2016.11.001 – start-page: e003725 year: 2016 ident: 2025052700565188800_euab065-B50 article-title: Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation – volume: 366 start-page: 9 year: 2012 ident: 2025052700565188800_euab065-B115 article-title: Rivaroxaban in patients with a recent acute coronary syndrome publication-title: N Engl J Med doi: 10.1056/NEJMoa1112277 – volume: 15 start-page: 112 year: 2015 ident: 2025052700565188800_euab065-B240 article-title: Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials publication-title: BMC Surg doi: 10.1186/s12893-015-0096-z – volume: 22 start-page: 460 year: 2015 ident: 2025052700565188800_euab065-B417 article-title: The pooled incidence of post-stroke seizure in 102 008 patients publication-title: Top Stroke Rehabil doi: 10.1179/1074935715Z.00000000062 – volume: 76 start-page: 2104 year: 2012 ident: 2025052700565188800_euab065-B101 article-title: Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation—the J-ROCKET AF study publication-title: Circ J doi: 10.1253/circj.CJ-12-0454 – volume: 44 start-page: 2935 year: 2013 ident: 2025052700565188800_euab065-B146 article-title: Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulants publication-title: Stroke doi: 10.1161/STROKEAHA.113.001701 – volume: 17 start-page: 1197 year: 2015 ident: 2025052700565188800_euab065-B229 article-title: Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS publication-title: Europace doi: 10.1093/europace/euv190 – volume: 388 start-page: 1161 year: 2016 ident: 2025052700565188800_euab065-B462 article-title: Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study publication-title: Lancet doi: 10.1016/S0140-6736(16)30968-0 – volume: 19 start-page: 3 year: 2017 ident: 2025052700565188800_euab065-B333 article-title: Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update publication-title: J Stroke doi: 10.5853/jos.2016.00864 – volume: 20 start-page: 619 year: 2011 ident: 2025052700565188800_euab065-B540 article-title: Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.2141 – volume: 19 start-page: 482 year: 2013 ident: 2025052700565188800_euab065-B481 article-title: Apixaban as an alternate oral anticoagulant for the management of patients with heparin-induced thrombocytopenia publication-title: Clin Appl Thromb Hemost doi: 10.1177/1076029613492876 – volume: 79 start-page: 838 year: 2015 ident: 2025052700565188800_euab065-B526 article-title: Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.12541 – volume: 7 start-page: 1333 year: 2014 ident: 2025052700565188800_euab065-B237 article-title: Direct oral anticoagulants: new drugs and new concepts publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2014.06.014 – volume: 18 start-page: 6 year: 2016 ident: 2025052700565188800_euab065-B14 article-title: Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial publication-title: Europace doi: 10.1093/europace/euv288 – volume: 179 start-page: 1469 year: 2019 ident: 2025052700565188800_euab065-B208 article-title: Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2019.2431 – volume: 22 start-page: 33 year: 2020 ident: 2025052700565188800_euab065-B252 article-title: Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials publication-title: Europace doi: 10.1093/europace/euz259 – volume: 57 start-page: 812 year: 2019 ident: 2025052700565188800_euab065-B349 article-title: Delayed intracranial hemorrhage in anticoagulated geriatric patients after ground level falls publication-title: J Emerg Med doi: 10.1016/j.jemermed.2019.09.011 – volume: 39 start-page: 2975 year: 2018 ident: 2025052700565188800_euab065-B52 article-title: A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy411 – volume: 44 start-page: 1891 year: 2013 ident: 2025052700565188800_euab065-B453 article-title: Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation publication-title: Stroke doi: 10.1161/STROKEAHA.113.000990 – volume: 129 start-page: 1850 year: 2014 ident: 2025052700565188800_euab065-B214 article-title: Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF) publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.005754 – volume: 15 start-page: 2125 year: 2017 ident: 2025052700565188800_euab065-B193 article-title: Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover study publication-title: J Thromb Haemost doi: 10.1111/jth.13815 – volume: 391 start-page: 41 year: 2018 ident: 2025052700565188800_euab065-B262 article-title: Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial publication-title: Lancet doi: 10.1016/S0140-6736(17)32713-7 – volume: 100 start-page: 1419 year: 2007 ident: 2025052700565188800_euab065-B548 article-title: Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study) publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2007.06.034 – volume: 172 start-page: 474 year: 2020 ident: 2025052700565188800_euab065-B251 article-title: Dual versus triple therapy for atrial fibrillation after percutaneous coronary intervention: a systematic review and meta-analysis publication-title: Ann Intern Med doi: 10.7326/M19-3763 – volume: 17 start-page: 1467 year: 2015 ident: 2025052700565188800_euab065-B9 article-title: Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation publication-title: Europace doi: 10.1093/europace/euv309 – volume: 123 start-page: 676 year: 2003 ident: 2025052700565188800_euab065-B231 article-title: Oral anticoagulation in surgical procedures: risks and recommendations publication-title: Br J Haematol doi: 10.1046/j.1365-2141.2003.04652.x – volume: 19 start-page: 3879 year: 2018 ident: 2025052700565188800_euab065-B303 article-title: Genetic polymorphisms associated with spontaneous intracerebral hemorrhage publication-title: Int J Mol Sci doi: 10.3390/ijms19123879 – volume: 5 start-page: 2178 year: 2007 ident: 2025052700565188800_euab065-B509 article-title: Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2007.02748.x – volume: 41 start-page: 3092 year: 2020 ident: 2025052700565188800_euab065-B88 article-title: Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients? publication-title: Eur Heart J doi: 10.1093/eurheartj/ehaa509 – volume: 358 start-page: 2765 year: 2008 ident: 2025052700565188800_euab065-B512 article-title: Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty publication-title: N Engl J Med doi: 10.1056/NEJMoa0800374 – volume: 50 start-page: 1102 year: 2009 ident: 2025052700565188800_euab065-B423 article-title: Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure publication-title: Epilepsia doi: 10.1111/j.1528-1167.2008.01945.x – volume: 97 start-page: 1566 year: 2011 ident: 2025052700565188800_euab065-B218 article-title: Non-cardiac surgery in patients with coronary stents: the RECO study publication-title: Heart doi: 10.1136/hrt.2011.224519 – volume: 128 start-page: 2325 year: 2013 ident: 2025052700565188800_euab065-B167 article-title: Management and outcomes of major bleeding during treatment with dabigatran or warfarin publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.002332 – volume: 02 start-page: e202 year: 2018 ident: 2025052700565188800_euab065-B161 article-title: Evaluation of the DOAC-Stop(R) procedure to overcome the effect of DOACs on several thrombophilia screening tests publication-title: TH Open doi: 10.1055/s-0038-1657785 – volume: 65 start-page: 2405 year: 2017 ident: 2025052700565188800_euab065-B313 article-title: Effect of new oral anticoagulants on prescribing practices for atrial fibrillation in older adults publication-title: J Am Geriatr Soc doi: 10.1111/jgs.15058 – volume: 45 start-page: 1672 year: 2014 ident: 2025052700565188800_euab065-B346 article-title: Vitamin K antagonists and risk of subdural hematoma: meta-analysis of randomized clinical trials publication-title: Stroke doi: 10.1161/STROKEAHA.114.005430 – volume: 70 start-page: 2022 year: 2017 ident: 2025052700565188800_euab065-B368 article-title: Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2017.09.002 – volume: 380 start-page: 1509 year: 2019 ident: 2025052700565188800_euab065-B244 article-title: Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1817083 – volume: 78 start-page: 877 year: 2014 ident: 2025052700565188800_euab065-B535 article-title: Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.12393 – volume: 75 start-page: 3122 year: 2020 ident: 2025052700565188800_euab065-B307 article-title: Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.04.067 – volume: 138 start-page: 1485 year: 2018 ident: 2025052700565188800_euab065-B71 article-title: Evolving changes of the use of oral anticoagulants and outcomes in patients with newly diagnosed atrial fibrillation in Taiwan publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.036046 – volume: 22 start-page: I32 year: 2020 ident: 2025052700565188800_euab065-B227 article-title: Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures publication-title: Eur Heart J Suppl doi: 10.1093/eurheartj/suaa102 – volume: 157 start-page: 1266 year: 2020 ident: 2025052700565188800_euab065-B326 article-title: Comparing the effectiveness and safety of nonvitamin K antagonist oral anticoagulants and warfarin in elderly Asian patients with atrial fibrillation: a nationwide cohort study publication-title: Chest doi: 10.1016/j.chest.2019.11.025 – ident: 2025052700565188800_euab065-B405 – volume: 156 start-page: 57 year: 2008 ident: 2025052700565188800_euab065-B310 article-title: Chronic atrial fibrillation: incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme publication-title: Am Heart J doi: 10.1016/j.ahj.2008.03.010 – volume: 368 start-page: 699 year: 2013 ident: 2025052700565188800_euab065-B503 article-title: Apixaban for extended treatment of venous thromboembolism publication-title: N Engl J Med doi: 10.1056/NEJMoa1207541 – volume: 76 start-page: 908 year: 2013 ident: 2025052700565188800_euab065-B379 article-title: Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.12114 – volume: 40 start-page: 1811 year: 2009 ident: 2025052700565188800_euab065-B460 article-title: Use of stroke secondary prevention services: are there disparities in care? publication-title: Stroke doi: 10.1161/STROKEAHA.108.539619 – volume: 126 start-page: 2309 year: 2012 ident: 2025052700565188800_euab065-B556 article-title: Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.101808 – volume: 19 start-page: 154 year: 2018 ident: 2025052700565188800_euab065-B360 article-title: Prestroke mobility and dementia as predictors of stroke outcomes in patients over 65 years of age: a cohort study from the Swedish Dementia and Stroke Registries publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2017.08.014 – volume: 17 start-page: 706 year: 2020 ident: 2025052700565188800_euab065-B358 article-title: Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: a population-based cohort study publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2020.01.007 – ident: 2025052700565188800_euab065-B253 article-title: Safety and efficacy of double versus triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of NOAC-based randomized clinical trials – volume: 38 start-page: 448 year: 2010 ident: 2025052700565188800_euab065-B95 article-title: In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies publication-title: Drug Metab Dispos doi: 10.1124/dmd.109.029694 – volume: 2 start-page: e000200 year: 2013 ident: 2025052700565188800_euab065-B440 article-title: Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure publication-title: JAHA doi: 10.1161/JAHA.113.000200 – volume: 353 start-page: 205 year: 1999 ident: 2025052700565188800_euab065-B338 article-title: A brief clinical instrument to classify frailty in elderly people publication-title: Lancet doi: 10.1016/S0140-6736(98)04402-X – volume: 36 start-page: e12457 year: 2018 ident: 2025052700565188800_euab065-B228 article-title: Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: a systematic review and meta-analysis publication-title: Cardiovasc Ther doi: 10.1111/1755-5922.12457 – volume: 13 start-page: 331 year: 2013 ident: 2025052700565188800_euab065-B523 article-title: Drug-drug interaction studies of cardiovascular drugs involving P-glycoprotein, an efflux transporter, on the pharmacokinetics of edoxaban, an oral factor Xa inhibitor publication-title: Am J Cardiovasc Drugs doi: 10.1007/s40256-013-0029-0 – volume: 23 start-page: 184 year: 2021 ident: 2025052700565188800_euab065-B356 article-title: Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation publication-title: Europace doi: 10.1093/europace/euaa192 – volume: 119 start-page: 1363 year: 2009 ident: 2025052700565188800_euab065-B118 article-title: Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.816082 – volume: 28 start-page: 2241 year: 2017 ident: 2025052700565188800_euab065-B136 article-title: Apixaban pharmacokinetics at steady state in hemodialysis patients publication-title: JASN doi: 10.1681/ASN.2016090980 – volume: 178 start-page: 101 year: 2019 ident: 2025052700565188800_euab065-B63 article-title: Dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a Danish nationwide cohort study publication-title: Thromb Res doi: 10.1016/j.thromres.2019.04.007 – volume: 383 start-page: 2117 year: 2020 ident: 2025052700565188800_euab065-B24 article-title: Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve publication-title: N Engl J Med doi: 10.1056/NEJMoa2029603 – volume: 8 start-page: 48 year: 2018 ident: 2025052700565188800_euab065-B297 article-title: Anticoagulation for atrial fibrillation after intracranial hemorrhage: a systematic review publication-title: Neurol Clin Pract doi: 10.1212/CPJ.0000000000000425 – volume: 151 start-page: 1105 year: 2016 ident: 2025052700565188800_euab065-B82 article-title: Association of proton pump inhibitors with reduced risk of warfarin-related serious upper gastrointestinal bleeding publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.08.054 – volume: 48 start-page: 528 year: 2019 ident: 2025052700565188800_euab065-B429 article-title: Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-019-01866-1 – volume: 40 start-page: 1569 year: 2019 ident: 2025052700565188800_euab065-B438 article-title: Challenges in clinical decision-making on concomitant drug therapies in patients with atrial fibrillation taking oral anticoagulants publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy784 – volume: 18 start-page: 1153 year: 2016 ident: 2025052700565188800_euab065-B39 article-title: Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48 publication-title: Eur J Heart Fail doi: 10.1002/ejhf.595 – volume: 149 start-page: 586 year: 2015 ident: 2025052700565188800_euab065-B79 article-title: Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.05.002 – volume: 107 start-page: 373 year: 2021 ident: 2025052700565188800_euab065-B89 article-title: Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis publication-title: Heart doi: 10.1136/heartjnl-2020-317901 – volume: 9 start-page: e014177 year: 2020 ident: 2025052700565188800_euab065-B67 article-title: Label adherence of direct oral anticoagulants dosing and clinical outcomes in patients with atrial fibrillation publication-title: J Am Heart Assoc doi: 10.1161/JAHA.119.014177 – volume: 40 start-page: 1553 year: 2019 ident: 2025052700565188800_euab065-B256 article-title: Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz059 – volume: 89 start-page: 1220 year: 2017 ident: 2025052700565188800_euab065-B420 article-title: Incidence and management of seizures after ischemic stroke: systematic review and meta-analysis publication-title: Neurology doi: 10.1212/WNL.0000000000004407 – start-page: e003432 year: 2016 ident: 2025052700565188800_euab065-B69 article-title: Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial – volume: 78 start-page: 412 year: 2005 ident: 2025052700565188800_euab065-B520 article-title: Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor publication-title: Clin Pharmacol Ther doi: 10.1016/j.clpt.2005.06.011 – volume: 144 start-page: 1555 year: 2013 ident: 2025052700565188800_euab065-B441 article-title: Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score publication-title: Chest doi: 10.1378/chest.13-0054 – volume: 37 start-page: 231 year: 2021 ident: 2025052700565188800_euab065-B90 article-title: Atrial fibrillation and the risk of 30-day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID-19 publication-title: J Arrhythm doi: 10.1002/joa3.12458 – volume: 64 start-page: 1128 year: 2014 ident: 2025052700565188800_euab065-B154 article-title: Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.05.065 – volume: 115 start-page: 256 year: 1991 ident: 2025052700565188800_euab065-B171 article-title: Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial publication-title: Ann Intern Med doi: 10.7326/0003-4819-115-4-256 – volume: 132 start-page: 1365 year: 2018 ident: 2025052700565188800_euab065-B42 article-title: Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome publication-title: Blood doi: 10.1182/blood-2018-04-848333 – volume: 194 start-page: 99 year: 2017 ident: 2025052700565188800_euab065-B332 article-title: Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: rationale and design of the ELDERCARE-AF study publication-title: Am Heart J doi: 10.1016/j.ahj.2017.08.017 – volume: 134 start-page: 1198 year: 2014 ident: 2025052700565188800_euab065-B510 article-title: Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial publication-title: Thromb Res doi: 10.1016/j.thromres.2014.09.011 – volume: 20 start-page: 285 year: 2011 ident: 2025052700565188800_euab065-B422 article-title: Early treatment after stroke for the prevention of late epileptic seizures: a report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis publication-title: Seizure doi: 10.1016/j.seizure.2010.12.012 – volume: 43 start-page: 769 year: 2020 ident: 2025052700565188800_euab065-B209 article-title: Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: the prospective, observational, and multinational EMIT-AF/VTE study publication-title: Clin Cardiol doi: 10.1002/clc.23379 – volume: 40 start-page: 3757 year: 2019 ident: 2025052700565188800_euab065-B250 article-title: Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz732 – volume: 2 start-page: 103 year: 2017 ident: 2025052700565188800_euab065-B421 article-title: European Stroke Organisation guidelines for the management of post-stroke seizures and epilepsy publication-title: Eur Stroke J doi: 10.1177/2396987317705536 – volume: 319 start-page: 463 year: 2018 ident: 2025052700565188800_euab065-B285 article-title: Association of intracerebral hemorrhage among patients taking non-vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality publication-title: JAMA doi: 10.1001/jama.2017.21917 – volume: 40 start-page: 442 year: 2018 ident: 2025052700565188800_euab065-B160 article-title: The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays publication-title: Int J Lab Hematol doi: 10.1111/ijlh.12807 – volume: 37 start-page: 74 year: 2009 ident: 2025052700565188800_euab065-B517 article-title: Apixaban metabolism and pharmacokinetics after oral administration to humans publication-title: Drug Metab Dispos doi: 10.1124/dmd.108.023143 – volume: 143 start-page: 92 year: 2008 ident: 2025052700565188800_euab065-B482 article-title: Rivaroxaban—an oral, direct Factor Xa inhibitor—has potential for the management of patients with heparin-induced thrombocytopenia publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2008.07300.x – volume: 14 start-page: 501 year: 2017 ident: 2025052700565188800_euab065-B410 article-title: Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2016.12.036 – volume: 35 start-page: 1864 year: 2014 ident: 2025052700565188800_euab065-B316 article-title: Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu046 – volume: 35 start-page: 1888 year: 2014 ident: 2025052700565188800_euab065-B215 article-title: Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry publication-title: Eur Heart J doi: 10.1093/eurheartj/eht557 – volume: 13 start-page: 1154 year: 2015 ident: 2025052700565188800_euab065-B5 article-title: Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH publication-title: J Thromb Haemost doi: 10.1111/jth.12969 – volume: 28 start-page: 109 year: 2013 ident: 2025052700565188800_euab065-B241 article-title: Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis publication-title: J Card Surg doi: 10.1111/jocs.12074 – volume: 60 start-page: 277 year: 2019 ident: 2025052700565188800_euab065-B68 article-title: Label adherence for non-vitamin K antagonist oral anticoagulants in a prospective cohort of Asian patients with atrial fibrillation publication-title: Yonsei Med J doi: 10.3349/ymj.2019.60.3.277 – volume: 21 start-page: 55 year: 2019 ident: 2025052700565188800_euab065-B296 article-title: Carotid atherosclerosis in patients with atrial fibrillation publication-title: Curr Atheroscler Rep doi: 10.1007/s11883-019-0808-4 – volume: 5 start-page: 59 year: 2013 ident: 2025052700565188800_euab065-B109 article-title: Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor publication-title: Clin Pharmacol – volume: 39 start-page: 2736 year: 2008 ident: 2025052700565188800_euab065-B445 article-title: Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation publication-title: Stroke doi: 10.1161/STROKEAHA.107.508580 – volume: 39 start-page: 2932 year: 2018 ident: 2025052700565188800_euab065-B128 article-title: Stroke prevention in atrial fibrillation: re-defining ‘real-world data’ within the broader data universe publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy236 – volume: 11 start-page: e0149142 year: 2016 ident: 2025052700565188800_euab065-B444 article-title: The influence of socioeconomic status on selection of anticoagulation for atrial fibrillation publication-title: PLoS One doi: 10.1371/journal.pone.0149142 – volume: 152 start-page: 81 year: 2017 ident: 2025052700565188800_euab065-B198 article-title: Direct oral anticoagulant- or warfarin-related major bleeding: characteristics, reversal strategies, and outcomes from a multicenter observational study publication-title: Chest doi: 10.1016/j.chest.2017.02.009 – volume: 5 start-page: 582 year: 2020 ident: 2025052700565188800_euab065-B249 article-title: Optimal antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary intervention: an updated network meta-analysis publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2019.6175 – volume: 82 start-page: 568 year: 2006 ident: 2025052700565188800_euab065-B415 article-title: Post-stroke seizure and post-stroke epilepsy publication-title: Postgrad Med J doi: 10.1136/pgmj.2005.041426 – volume: 373 start-page: 2038 year: 2015 ident: 2025052700565188800_euab065-B260 article-title: Polymer-free drug-coated coronary stents in patients at high bleeding risk publication-title: N Engl J Med doi: 10.1056/NEJMoa1503943 – volume: 141 start-page: 1618 year: 2020 ident: 2025052700565188800_euab065-B255 article-title: Risk/benefit tradeoff of antithrombotic therapy in patients with atrial fibrillation early and late after an acute coronary syndrome or percutaneous coronary intervention: insights from AUGUSTUS publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.120.046534 – volume: 194 start-page: 132 year: 2017 ident: 2025052700565188800_euab065-B51 article-title: International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries publication-title: Am Heart J doi: 10.1016/j.ahj.2017.08.011 – volume: 36 start-page: 624 year: 2014 ident: 2025052700565188800_euab065-B553 article-title: Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulant publication-title: Ther Drug Monit doi: 10.1097/FTD.0000000000000064 – volume: 20 start-page: 157 year: 2018 ident: 2025052700565188800_euab065-B230 article-title: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary publication-title: Europace doi: 10.1093/europace/eux275 – volume: 373 start-page: 823 year: 2015 ident: 2025052700565188800_euab065-B212 article-title: Perioperative bridging anticoagulation in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1501035 – volume: 115 start-page: 47 year: 2015 ident: 2025052700565188800_euab065-B554 article-title: Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2014.10.005 – volume: 10 start-page: 90 year: 2013 ident: 2025052700565188800_euab065-B367 article-title: Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2012.08.043 – volume: 184 start-page: 912 year: 2019 ident: 2025052700565188800_euab065-B158 article-title: Progress in the monitoring of direct oral anticoagulant therapy publication-title: Br J Haematol doi: 10.1111/bjh.15756 – volume: 138 start-page: 163 year: 2018 ident: 2025052700565188800_euab065-B334 article-title: Microbleeds in ischemic vs hemorrhagic strokes on novel oral anticoagulants publication-title: Acta Neurol Scand doi: 10.1111/ane.12934 – volume: 9 start-page: e009530 year: 2020 ident: 2025052700565188800_euab065-B44 article-title: Impact of modifiable bleeding risk factors on major bleeding in patients with atrial fibrillation anticoagulated with rivaroxaban publication-title: J Am Heart Assoc doi: 10.1161/JAHA.118.009530 – volume: 22 start-page: 47 year: 2019 ident: 2025052700565188800_euab065-B58 article-title: Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme publication-title: Europace – volume: 36 start-page: 531.e1–2 year: 2018 ident: 2025052700565188800_euab065-B476 article-title: Drug-induced thrombocytopenia after anticoagulation with rivaroxaban publication-title: Am J Emerg Med doi: 10.1016/j.ajem.2017.12.052 – volume: 18 start-page: 1609– year: 2016 ident: 2025052700565188800_euab065-B11 article-title: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS publication-title: Europace doi: 10.1093/europace/euw295 – volume: 209 start-page: 181 year: 2016 ident: 2025052700565188800_euab065-B23 article-title: Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2016.02.005 – volume: 50 start-page: 309 year: 2007 ident: 2025052700565188800_euab065-B449 article-title: Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.01.098 – volume: 278 start-page: 1 year: 2015 ident: 2025052700565188800_euab065-B84 article-title: Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation publication-title: J Intern Med doi: 10.1111/joim.12360 – volume: 119 start-page: 2877 year: 2009 ident: 2025052700565188800_euab065-B116 article-title: Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.832139 – volume: 68 start-page: 2597 year: 2016 ident: 2025052700565188800_euab065-B61 article-title: Off-Label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II Registry publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.09.966 – volume: 38 start-page: 2431 year: 2017 ident: 2025052700565188800_euab065-B162 article-title: Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx403 – volume: 2 start-page: 566 year: 2017 ident: 2025052700565188800_euab065-B164 article-title: Laboratory monitoring of non-vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation: a review publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2017.0364 – volume: 15 start-page: 491 year: 2017 ident: 2025052700565188800_euab065-B159 article-title: Interference of direct oral anticoagulants in haemostasis assays: high potential for diagnostic false positives and false negatives publication-title: Blood Transfus – volume: 4 start-page: 198 year: 2019 ident: 2025052700565188800_euab065-B280 article-title: Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: a European Stroke Organisation guideline publication-title: Eur Stroke J doi: 10.1177/2396987319841187 – volume: 17 start-page: 143 year: 2018 ident: 2025052700565188800_euab065-B424 article-title: Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(17)30404-0 – volume: 130 start-page: 956 year: 2012 ident: 2025052700565188800_euab065-B148 article-title: Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature publication-title: Thromb Res doi: 10.1016/j.thromres.2012.09.004 – volume: 40 start-page: 1541 year: 2019 ident: 2025052700565188800_euab065-B381 article-title: Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy861 – ident: 2025052700565188800_euab065-B496 – ident: 2025052700565188800_euab065-B473 – volume: 211 start-page: 77 year: 2019 ident: 2025052700565188800_euab065-B330 article-title: Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation publication-title: Am Heart J doi: 10.1016/j.ahj.2019.01.005 – volume: 127 start-page: 111 year: 2017 ident: 2025052700565188800_euab065-B195 article-title: Management of severe bleeding in patients treated with direct oral anticoagulants: an observational registry analysis publication-title: Anesthesiology doi: 10.1097/ALN.0000000000001631 – volume: 36 start-page: 58 year: 2021 ident: 2025052700565188800_euab065-B199 article-title: Four-factor prothrombin complex concentrate for the reversal of direct oral anticoagulants publication-title: J Intensive Care Med doi: 10.1177/0885066619882909 – volume: 377 start-page: 1319 year: 2017 ident: 2025052700565188800_euab065-B516 article-title: Rivaroxaban with or without aspirin in stable cardiovascular disease publication-title: N Engl J Med doi: 10.1056/NEJMoa1709118 – year: 2020 ident: 2025052700565188800_euab065-B254 article-title: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehaa624 – volume: 50 start-page: 2245 year: 2019 ident: 2025052700565188800_euab065-B55 article-title: Effectiveness and safety of contemporary oral anticoagulants among Asians with nonvalvular atrial fibrillation publication-title: Stroke doi: 10.1161/STROKEAHA.119.025536 – volume: 70 start-page: 299 year: 2019 ident: 2025052700565188800_euab065-B287 article-title: Noncardioembolic stroke in patients with atrial fibrillation publication-title: Angiology doi: 10.1177/0003319718791711 – volume: 136 start-page: 2420 year: 2017 ident: 2025052700565188800_euab065-B31 article-title: Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.029267 – volume: 13 start-page: e005894 year: 2020 ident: 2025052700565188800_euab065-B54 article-title: Effectiveness and safety of direct oral anticoagulants in relation to temporal changes in their use publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.119.005894 – volume: 2 start-page: 200 year: 2018 ident: 2025052700565188800_euab065-B491 article-title: Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation publication-title: Blood Adv doi: 10.1182/bloodadvances.2017010694 – volume: 20 start-page: 1231 year: 2018 ident: 2025052700565188800_euab065-B10a article-title: The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary publication-title: Europace doi: 10.1093/europace/euy054 – volume: 13 start-page: e0191592 year: 2018 ident: 2025052700565188800_euab065-B321 article-title: Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: rationale for comprehensive management of atrial fibrillation publication-title: PLoS One doi: 10.1371/journal.pone.0191592 – volume: 40 start-page: 1518 year: 2019 ident: 2025052700565188800_euab065-B452 article-title: Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy807 – volume: 40 start-page: 1688 year: 2012 ident: 2025052700565188800_euab065-B530 article-title: Absence of clinically relevant interactions between rivaroxaban—an oral, direct Factor Xa inhibitor–and digoxin or atorvastatin in healthy subjects publication-title: J Int Med Res doi: 10.1177/030006051204000508 – volume: 163 start-page: 190 year: 2018 ident: 2025052700565188800_euab065-B406 article-title: The effect of bariatric surgery on direct-acting oral anticoagulant drug levels publication-title: Thromb Res doi: 10.1016/j.thromres.2017.11.006 – start-page: e007633 year: 2018 ident: 2025052700565188800_euab065-B62 article-title: Frequency and outcomes of reduced dose non-vitamin K antagonist anticoagulants: results from ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II) – volume: 4 start-page: 3520 year: 2020 ident: 2025052700565188800_euab065-B211 article-title: Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure publication-title: Blood Adv doi: 10.1182/bloodadvances.2020002335 – volume: 4 start-page: 108 year: 2014 ident: 2025052700565188800_euab065-B401 article-title: Warfarin dosing after bariatric surgery: a retrospective study of 10 patients previously stable on chronic warfarin therapy publication-title: Clin Obes doi: 10.1111/cob.12046 – volume: 28 start-page: 1534 year: 2019 ident: 2025052700565188800_euab065-B434 article-title: Poor concordance among drug compendia for proposed interactions between enzyme-inducing antiepileptic drugs and direct oral anticoagulants publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.4896 – volume: 5 start-page: 268 year: 2017 ident: 2025052700565188800_euab065-B478 article-title: Case report: apixaban-induced thrombocytopenia publication-title: Clin Case Rep doi: 10.1002/ccr3.809 – volume: 36 start-page: 2017 year: 2018 ident: 2025052700565188800_euab065-B467 article-title: Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D) publication-title: J Clin Oncol doi: 10.1200/JCO.2018.78.8034 – volume: 39 start-page: 601 year: 2001 ident: 2025052700565188800_euab065-B206 article-title: How long after drug ingestion is activated charcoal still effective? publication-title: J Toxicol Clin Toxicol doi: 10.1081/CLT-100108492 – volume: 371 start-page: 2155 year: 2014 ident: 2025052700565188800_euab065-B263 article-title: Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents publication-title: N Engl J Med doi: 10.1056/NEJMoa1409312 – volume: 39 start-page: 1330 year: 2018 ident: 2025052700565188800_euab065-B10 article-title: The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy136 – volume: 34 start-page: 841 year: 2017 ident: 2025052700565188800_euab065-B314 article-title: Underuse of anticoagulation in older patients with atrial fibrillation and CHADS2 score >/= 2: are we doing better since the marketing of direct oral anticoagulants? publication-title: Drugs Aging doi: 10.1007/s40266-017-0493-3 – volume: 41 start-page: 2132 year: 2010 ident: 2025052700565188800_euab065-B461 article-title: Mexican Americans with atrial fibrillation have more recurrent strokes than do non-Hispanic whites publication-title: Stroke doi: 10.1161/STROKEAHA.110.589127 – volume: 23 start-page: 1515 year: 2013 ident: 2025052700565188800_euab065-B400 article-title: Warfarin users prone to coagulopathy in first 30 days after hospital discharge from gastric bypass publication-title: Obes Surg doi: 10.1007/s11695-013-0972-5 – volume: 45 start-page: 275 year: 2019 ident: 2025052700565188800_euab065-B151 article-title: Detecting anti-IIa and anti-Xa direct oral anticoagulant (DOAC) agents in urine using a DOAC dipstick publication-title: Semin Thromb Hemost doi: 10.1055/s-0038-1668098 – volume: 51 start-page: 883 year: 2020 ident: 2025052700565188800_euab065-B289 article-title: Early initiation of direct oral anticoagulants after onset of stroke and short- and long-term outcomes of patients with nonvalvular atrial fibrillation publication-title: Stroke doi: 10.1161/STROKEAHA.119.028118 – volume: 28 start-page: 190 year: 2020 ident: 2025052700565188800_euab065-B281 article-title: Restarting oral anticoagulation in patients with atrial fibrillation after an intracranial hemorrhage publication-title: Cardiol Rev doi: 10.1097/CRD.0000000000000288 – volume: 62 start-page: 212 year: 2013 ident: 2025052700565188800_euab065-B536 article-title: The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitor publication-title: J Cardiovasc Pharmacol doi: 10.1097/FJC.0b013e3182970991 – volume: 378 start-page: 615 year: 2018 ident: 2025052700565188800_euab065-B466 article-title: Edoxaban for the treatment of cancer-associated venous thromboembolism publication-title: N Engl J Med doi: 10.1056/NEJMoa1711948 – volume: 24 start-page: 201 year: 2018 ident: 2025052700565188800_euab065-B483 article-title: Emerging role of direct oral anticoagulants in the management of heparin-induced thrombocytopenia publication-title: Clin Appl Thromb Hemost doi: 10.1177/1076029617696582 – volume: 69 start-page: 1372 year: 2017 ident: 2025052700565188800_euab065-B20 article-title: Valvular heart disease patients on edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.12.031 – volume: 39 start-page: 861 year: 2019 ident: 2025052700565188800_euab065-B236 article-title: Intraoperative unfractionated heparin unresponsiveness during endovascular repair of a ruptured abdominal aortic aneurysm following administration of andexanet alfa for the reversal of rivaroxaban publication-title: Pharmacotherapy doi: 10.1002/phar.2306 – volume: 369 start-page: 2093 year: 2013 ident: 2025052700565188800_euab065-B49 article-title: Edoxaban versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1310907 – volume: 33 start-page: 2821 year: 2012 ident: 2025052700565188800_euab065-B127 article-title: Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs274 – ident: 2025052700565188800_euab065-B408 – volume: 6 start-page: 1165 year: 2017 ident: 2025052700565188800_euab065-B493 article-title: Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study publication-title: Cancer Med doi: 10.1002/cam4.1054 – volume: 361 start-page: 1139 year: 2009 ident: 2025052700565188800_euab065-B48 article-title: Dabigatran versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa0905561 – volume: 58 start-page: 965 year: 2018 ident: 2025052700565188800_euab065-B397 article-title: Regional gastrointestinal absorption of apixaban in healthy subjects publication-title: J Clin Pharmacol doi: 10.1002/jcph.1097 – volume: 43 start-page: 343 year: 2017 ident: 2025052700565188800_euab065-B398 article-title: Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs) publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-016-1465-x – volume: 126 start-page: 343 year: 2012 ident: 2025052700565188800_euab065-B187 article-title: Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.090464 – volume: 124 start-page: 3692 year: 2014 ident: 2025052700565188800_euab065-B213 article-title: Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures publication-title: Blood doi: 10.1182/blood-2014-08-595496 – volume: 11 start-page: 756 year: 2013 ident: 2025052700565188800_euab065-B155 article-title: Measuring oral direct inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis publication-title: J Thromb Haemost doi: 10.1111/jth.12149 – volume: 38 start-page: 860 year: 2017 ident: 2025052700565188800_euab065-B87 article-title: Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2 publication-title: Eur Heart J – volume: 138 start-page: 1519 year: 2018 ident: 2025052700565188800_euab065-B142 article-title: Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.035418 – volume: 45 start-page: 1739 year: 2014 ident: 2025052700565188800_euab065-B454 article-title: Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial publication-title: Stroke doi: 10.1161/STROKEAHA.113.002968 – volume: 76 start-page: 594 year: 2020 ident: 2025052700565188800_euab065-B174 article-title: 2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Solution Set Oversight Committee publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.04.053 – volume: 117 start-page: 5044 year: 2011 ident: 2025052700565188800_euab065-B216 article-title: Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach publication-title: Blood doi: 10.1182/blood-2011-02-329979 – volume: 190 start-page: 63 year: 2015 ident: 2025052700565188800_euab065-B271 article-title: Uninterrupted dabigatran versus warfarin in the treatment of intracardiac thrombus in patients with non-valvular atrial fibrillation publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2015.04.104 – volume: 15 start-page: 625 year: 2013 ident: 2025052700565188800_euab065-B8 article-title: European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation publication-title: Europace doi: 10.1093/europace/eut083 – volume: 45 start-page: 555 year: 2005 ident: 2025052700565188800_euab065-B404 article-title: Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement publication-title: J Clin Pharmacol doi: 10.1177/0091270005274550 – volume: 51 start-page: 1464 year: 2020 ident: 2025052700565188800_euab065-B309 article-title: Non-traumatic subdural hemorrhage and risk of arterial ischemic events publication-title: Stroke doi: 10.1161/STROKEAHA.119.028510 – volume: 76 start-page: 776 year: 2013 ident: 2025052700565188800_euab065-B550 article-title: Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.12106 – volume: 158 start-page: 111 year: 2009 ident: 2025052700565188800_euab065-B458 article-title: Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study publication-title: Am Heart J doi: 10.1016/j.ahj.2009.05.010 – volume: 374 start-page: 1911 year: 2016 ident: 2025052700565188800_euab065-B238 article-title: Rate control versus rhythm control for atrial fibrillation after cardiac surgery publication-title: N Engl J Med doi: 10.1056/NEJMoa1602002 – volume: 14 start-page: 179 year: 2016 ident: 2025052700565188800_euab065-B81 article-title: Effective and safe proton pump inhibitor therapy in acid-related diseases—a position paper addressing benefits and potential harms of acid suppression publication-title: BMC Med doi: 10.1186/s12916-016-0718-z – volume: 4 start-page: 307 year: 2019 ident: 2025052700565188800_euab065-B293 article-title: Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018 publication-title: Eur Stroke J doi: 10.1177/2396987319863606 – volume: 46 start-page: 549 year: 2006 ident: 2025052700565188800_euab065-B105 article-title: Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects publication-title: J Clin Pharmacol doi: 10.1177/0091270006286904 – volume: 364 start-page: 806 year: 2011 ident: 2025052700565188800_euab065-B284 article-title: Apixaban in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1007432 – volume: 181 start-page: 76 year: 2019 ident: 2025052700565188800_euab065-B308 article-title: Dabigatran reversal by idarucizumab in the setting of intracranial hemorrhage: a systematic review of the literature publication-title: Clin Neurol Neurosurg doi: 10.1016/j.clineuro.2019.04.013 – volume: 88 start-page: 86 year: 2017 ident: 2025052700565188800_euab065-B425 article-title: The prognosis of acute symptomatic seizures after ischaemic stroke publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2015-311849 – volume: 7 start-page: e18 year: 2020 ident: 2025052700565188800_euab065-B40 article-title: Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial publication-title: Lancet Haematol doi: 10.1016/S2352-3026(19)30219-4 – volume: 1 start-page: 673 year: 2016 ident: 2025052700565188800_euab065-B103 article-title: Apixaban 5 mg twice daily and clinical outcomes in patients with atrial fibrillation and advanced age, low body weight, or high creatinine: a secondary analysis of a randomized clinical trial publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2016.1829 – volume: 19 start-page: 1896 year: 2017 ident: 2025052700565188800_euab065-B327 article-title: Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey publication-title: Europace doi: 10.1093/europace/eux288 – volume: 54 start-page: 1280 year: 2009 ident: 2025052700565188800_euab065-B439 article-title: Quality of care for atrial fibrillation among patients hospitalized for heart failure publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.04.091 – volume: 51 start-page: 416 year: 2020 ident: 2025052700565188800_euab065-B299 article-title: Oral anticoagulation in Asian patients with atrial fibrillation and a history of intracranial hemorrhage publication-title: Stroke doi: 10.1161/STROKEAHA.119.028030 – volume: 8 start-page: 928 year: 2020 ident: 2025052700565188800_euab065-B475 article-title: Acute thrombocytopenia after anticoagulation with rivaroxaban: a case report publication-title: World J Clin Cases doi: 10.12998/wjcc.v8.i5.928 – volume: 103 start-page: 1015 year: 2017 ident: 2025052700565188800_euab065-B317 article-title: Effects of dabigatran according to age in atrial fibrillation publication-title: Heart doi: 10.1136/heartjnl-2016-310358 – volume: 67 start-page: 1272 year: 2006 ident: 2025052700565188800_euab065-B175 article-title: Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP publication-title: Neurology doi: 10.1212/01.wnl.0000238104.75563.2f – ident: 2025052700565188800_euab065-B183 – ident: 2025052700565188800_euab065-B92 – volume: 77 start-page: 1785 year: 2011 ident: 2025052700565188800_euab065-B418 article-title: Incidence and predictors of acute symptomatic seizures after stroke publication-title: Neurology doi: 10.1212/WNL.0b013e3182364878 – volume: 145 start-page: 963 year: 2017 ident: 2025052700565188800_euab065-B442 article-title: [Features, management and prognosis of Chilean patients with non valvular atrial fibrillation: GARFIELD AF registry] publication-title: Rev Med Chil – volume: 130 start-page: 138 year: 2014 ident: 2025052700565188800_euab065-B315 article-title: Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.005008 – volume: 121 start-page: 140 year: 2021 ident: 2025052700565188800_euab065-B382 article-title: Edoxaban versus warfarin in patients with atrial fibrillation at the extremes of body weight: an analysis from the ENGAGE AF-TIMI 48 trial publication-title: Thromb Haemost doi: 10.1055/s-0040-1716540 – volume: 35 start-page: 447 year: 2015 ident: 2025052700565188800_euab065-B532 article-title: The effect of rifampin on the pharmacokinetics of edoxaban in healthy adults publication-title: Clin Drug Investig doi: 10.1007/s40261-015-0298-2 – volume: 132 start-page: 624 year: 2015 ident: 2025052700565188800_euab065-B17 article-title: Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.014807 – volume: 47 start-page: 218 year: 2007 ident: 2025052700565188800_euab065-B378 article-title: Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjects publication-title: J Clin Pharmacol doi: 10.1177/0091270006296058 – volume: 131 start-page: 157 year: 2015 ident: 2025052700565188800_euab065-B318 article-title: Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.012061 – volume: 373 start-page: 1673 year: 2009 ident: 2025052700565188800_euab065-B515 article-title: Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial publication-title: Lancet doi: 10.1016/S0140-6736(09)60734-0 – volume: 66 start-page: 1339 year: 2015 ident: 2025052700565188800_euab065-B446 article-title: Age threshold for increased stroke risk among patients with atrial fibrillation: a nationwide cohort study from Taiwan publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.07.026 – volume: 49 start-page: 259 year: 2010 ident: 2025052700565188800_euab065-B184 article-title: Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study publication-title: Clin Pharmacokinet doi: 10.2165/11318170-000000000-00000 – volume: 35(Suppl 2 start-page: ii37 year: 2006 ident: 2025052700565188800_euab065-B342 article-title: Falls in older people: epidemiology, risk factors and strategies for prevention publication-title: Age Ageing doi: 10.1093/ageing/afl084 – volume: 37 start-page: 2768 year: 2016 ident: 2025052700565188800_euab065-B495 article-title: 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw211 – volume: 18 start-page: 117 year: 2019 ident: 2025052700565188800_euab065-B290 article-title: Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation publication-title: Lancet Neurol doi: 10.1016/S1474-4422(18)30356-9 – volume: 19 start-page: 82 year: 2014 ident: 2025052700565188800_euab065-B494 article-title: New oral anticoagulants and the cancer patient publication-title: Oncologist doi: 10.1634/theoncologist.2013-0239 – volume: 370 start-page: 1494 year: 2014 ident: 2025052700565188800_euab065-B219 article-title: Aspirin in patients undergoing noncardiac surgery publication-title: N Engl J Med doi: 10.1056/NEJMoa1401105 – volume: 69 start-page: 777 year: 2017 ident: 2025052700565188800_euab065-B324 article-title: The changing landscape for stroke prevention in AF: findings from the GLORIA-AF Registry Phase 2 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.11.061 – volume: 28 start-page: 1537 year: 2008 ident: 2025052700565188800_euab065-B402 article-title: Warfarin resistance after total gastrectomy and Roux-en-Y esophagojejunostomy publication-title: Pharmacotherapy doi: 10.1592/phco.28.12.1537 – volume: 365 start-page: 981 year: 2011 ident: 2025052700565188800_euab065-B47 article-title: Apixaban versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1107039 – volume: 33 start-page: 2163 year: 2012 ident: 2025052700565188800_euab065-B96 article-title: A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs167 – volume: 367 start-page: 625 year: 2012 ident: 2025052700565188800_euab065-B129 article-title: Stroke and bleeding in atrial fibrillation with chronic kidney disease publication-title: N Engl J Med doi: 10.1056/NEJMoa1105594 – volume: 48 start-page: 857 year: 2017 ident: 2025052700565188800_euab065-B385 article-title: Is there an obesity paradox for outcomes in atrial fibrillation? A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant trials publication-title: Stroke doi: 10.1161/STROKEAHA.116.015984 – volume: 38 start-page: 2612 year: 2017 ident: 2025052700565188800_euab065-B354 article-title: Atrial fibrillation as a risk factor for cognitive decline and dementia publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx208 – volume: 2015 start-page: 117 year: 2015 ident: 2025052700565188800_euab065-B178 article-title: Monitoring and reversal of direct oral anticoagulants publication-title: Hematology Am Soc Hematol Educ Program doi: 10.1182/asheducation.V2015.1.117.3916182 – volume: 14 start-page: 2559 year: 2016 ident: 2025052700565188800_euab065-B210 article-title: To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply publication-title: J Thromb Haemost doi: 10.1111/jth.13513 – volume: 126 start-page: 98 year: 2016 ident: 2025052700565188800_euab065-B426 article-title: Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2016.06.003 – volume: 139 start-page: 787 year: 2019 ident: 2025052700565188800_euab065-B331 article-title: Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.035012 – volume: 20 start-page: 106 year: 2018 ident: 2025052700565188800_euab065-B305 article-title: The clinical dilemma of anticoagulation use in patients with cerebral amyloid angiopathy and atrial fibrillation publication-title: Curr Cardiol Rep doi: 10.1007/s11886-018-1052-1 – volume: 17 start-page: 2102 year: 2020 ident: 2025052700565188800_euab065-B66 article-title: Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2020.07.022 – volume: 10 start-page: e037234 year: 2020 ident: 2025052700565188800_euab065-B291 article-title: Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry publication-title: BMJ Open doi: 10.1136/bmjopen-2020-037234 – volume: 346 start-page: 366 year: 2014 ident: 2025052700565188800_euab065-B387 article-title: Rivaroxaban presents a better pharmacokinetic profile than dabigatran in an obese non-diabetic stroke patient publication-title: J Neurol Sci doi: 10.1016/j.jns.2014.09.008 – volume: 33 start-page: 2766 year: 2012 ident: 2025052700565188800_euab065-B122 article-title: Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs267 – volume: 375 start-page: 2423 year: 2016 ident: 2025052700565188800_euab065-B246 article-title: Prevention of bleeding in patients with atrial fibrillation undergoing PCI publication-title: N Engl J Med doi: 10.1056/NEJMoa1611594 – volume: 157 start-page: 403 year: 2019 ident: 2025052700565188800_euab065-B78 article-title: Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and/or aspirin in a randomized, double-blind, placebo-controlled trial publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.04.041 – volume: 38 start-page: 2739 year: 2017 ident: 2025052700565188800_euab065-B13 article-title: 2017 ESC/EACTS Guidelines for the management of valvular heart disease publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx391 – volume: 68 start-page: 1169 year: 2016 ident: 2025052700565188800_euab065-B70 article-title: Edoxaban versus warfarin in atrial fibrillation patients at risk of falling: ENGAGE AF-TIMI 48 analysis publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.06.034 – volume: 12 start-page: 1428 year: 2014 ident: 2025052700565188800_euab065-B194 article-title: Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers publication-title: J Thromb Haemost doi: 10.1111/jth.12599 – volume: 103 start-page: 1116 year: 2010 ident: 2025052700565188800_euab065-B549 article-title: Dabigatran etexilate—a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity publication-title: Thromb Haemost doi: 10.1160/TH09-11-0758 – volume: 33 start-page: 345 year: 2017 ident: 2025052700565188800_euab065-B4 article-title: 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation publication-title: J Arrhythm doi: 10.1016/j.joa.2017.05.004 – volume: 119 start-page: 1248 year: 2012 ident: 2025052700565188800_euab065-B480 article-title: Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies publication-title: Blood doi: 10.1182/blood-2011-05-353391 – volume: 32 start-page: 673 year: 2010 ident: 2025052700565188800_euab065-B552 article-title: Assays for measuring rivaroxaban: their suitability and limitations publication-title: Ther Drug Monit doi: 10.1097/FTD.0b013e3181f2f264 – volume: 38 start-page: 1674 year: 2016 ident: 2025052700565188800_euab065-B110 article-title: Evaluation of crushed tablet for oral administration and the effect of food on apixaban pharmacokinetics in healthy adults publication-title: Clin Ther doi: 10.1016/j.clinthera.2016.05.004 – volume: 64 start-page: 930 year: 2012 ident: 2025052700565188800_euab065-B539 article-title: The transport of antiepileptic drugs by P-glycoprotein publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2011.12.003 – volume: 67 start-page: 2888 year: 2016 ident: 2025052700565188800_euab065-B145 article-title: Nonvitamin K anticoagulant agents in patients with advanced chronic kidney disease or on dialysis with AF publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.02.082 – volume: 229 start-page: 81 year: 2020 ident: 2025052700565188800_euab065-B322 article-title: Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: a nationwide population-based study publication-title: Am Heart J doi: 10.1016/j.ahj.2020.08.006 – volume: 3 start-page: 856 year: 2005 ident: 2025052700565188800_euab065-B411 article-title: The influence of extreme body weight on clinical outcome of patients with venous thromboembolism: findings from a prospective registry (RIETE) publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2005.01304.x – volume: 12 start-page: 7 year: 2014 ident: 2025052700565188800_euab065-B153 article-title: Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs publication-title: Thromb J doi: 10.1186/1477-9560-12-7 – volume: 63 start-page: 2141 year: 2014 ident: 2025052700565188800_euab065-B165 article-title: Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): predictors, characteristics, and clinical outcomes publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.02.549 – volume: 390 start-page: 1747 year: 2017 ident: 2025052700565188800_euab065-B257 article-title: Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial publication-title: Lancet doi: 10.1016/S0140-6736(17)32155-4 – volume: 18 start-page: 1180 year: 2011 ident: 2025052700565188800_euab065-B428 article-title: The effect of antiepileptic drugs on coagulation and bleeding in the perioperative period of epilepsy surgery: the Cleveland Clinic experience publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2011.02.018 – volume: 120 start-page: 27 year: 2020 ident: 2025052700565188800_euab065-B182 article-title: Global use of idarucizumab in clinical practice: outcomes of the RE-VECTO Surveillance Program publication-title: Thromb Haemost doi: 10.1055/s-0039-1695771 – volume: 53 start-page: 5 year: 2018 ident: 2025052700565188800_euab065-B235 article-title: 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery publication-title: Eur J Cardiothorac Surg doi: 10.1093/ejcts/ezx314 – volume: 130 start-page: 1104 year: 2017 ident: 2025052700565188800_euab065-B484 article-title: Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review publication-title: Blood doi: 10.1182/blood-2017-04-778993 – volume: 18 start-page: 526 year: 2019 ident: 2025052700565188800_euab065-B73 article-title: The impact of nurse-led atrial fibrillation clinics on patient and healthcare outcomes: a systematic mixed studies review publication-title: Eur J Cardiovasc Nurs doi: 10.1177/1474515119845198 – volume: 51 start-page: 2153 year: 2020 ident: 2025052700565188800_euab065-B302 article-title: Combining imaging and genetics to predict recurrence of anticoagulation-associated intracerebral hemorrhage publication-title: Stroke doi: 10.1161/STROKEAHA.120.028310 – reference: 34480553 - Europace. 2021 Oct 9;23(10):1685. doi: 10.1093/europace/euab217. – reference: 34549782 - Europace. 2021 Oct 9;23(10):1686. doi: 10.1093/europace/euab219. – reference: 34549781 - Europace. 2021 Oct 9;23(10):1686-1687. doi: 10.1093/europace/euab220. – reference: 34179979 - Europace. 2021 Oct 9;23(10):1676. doi: 10.1093/europace/euab157. – reference: 34480550 - Europace. 2021 Oct 9;23(10):1685-1686. doi: 10.1093/europace/euab218.
SSID	ssj0007295
Score	2.7232265
SecondaryResourceType	review_article
SourceID	unpaywall swepub pubmedcentral proquest pubmed crossref oup
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	1612
SubjectTerms	Administration, Oral Anticoagulants - adverse effects apixaban Atrial Fibrillation - complications Atrial Fibrillation - diagnosis Atrial Fibrillation - drug therapy dabigatran Dabigatran - therapeutic use DOACs edoxaban EHRA Practical Guide Humans NOACs Official Statement Pyridones - therapeutic use rivaroxaban Rivaroxaban - therapeutic use Stroke - diagnosis Stroke - etiology Stroke - prevention & control
Title	2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
URI	https://www.ncbi.nlm.nih.gov/pubmed/33895845 https://www.proquest.com/docview/2518740908 https://pubmed.ncbi.nlm.nih.gov/PMC11636576 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-459047 https://academic.oup.com/europace/article-pdf/23/10/1612/40544687/euab065.pdf
UnpaywallVersion	publishedVersion
Volume	23
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1532-2092 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: KQ8 dateStart: 19990101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1532-2092 dateEnd: 20241003 omitProxy: true ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: DIK dateStart: 19990101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1532-2092 dateEnd: 20241003 omitProxy: true ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: GX1 dateStart: 19990101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1532-2092 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: RPM dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVASL databaseName: Oxford Journals Open Access Collection customDbUrl: eissn: 1532-2092 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: TOX dateStart: 19990101 isFulltext: true titleUrlDefault: https://academic.oup.com/journals/ providerName: Oxford University Press
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Zj9MwEB7tdiWOB84FwrEy0vIAUpo0cdL4MQJKBWp3hbar8hQ5h7cRWadqE6Hlh_B7GTdOaUDikMhTFI8dxR5rvsnMfAY4HmZ4JVyFBoeeSeMsNZkq1BUJGnuE5-ghqHrnydQfz-j7uTffg0lbC8N1Vni_LWlQFBXoPWaWnklzmQrLcXG3WwhWHAsBB3o0wRAFeYz2tI_t-3Dgq3hTDw5m09Pw0ybiyZipjFvDn-qgdjBHhy3Rqf_xGj1Mx0x1St92EOiviZSabvQmXK_lkl994UWxY65Gt0G2H9pkqXzu11XcT77-xAH532biDtzSwJaETa-7sJfJe3BtokP39-Gbg3aetD__yRh3WEU-Lq6qxSXZ0RHSECih5pB3dZ5mBB8hRiWzNd4KMi2leZ5X_DKX5AMJpYqpKe5fcrJSL5fYs-QXdaGyewjKnDa0sWui_jeTcHNGCRmpMoeiSQI8hNno7dnrsakPhTATyoLKjG1hO1mAOMdNcR154AiPZo6dJo7tCTGkgbBjP7YV9SS6kohXsTnwVHxXcD4YuA-gJ0uZPQLipVSknDE6iAPKbBwqcV2fc0ERlqa2MMBqdSBKNGO6OrijiJrIvRu1SxLpKTfg5bbHsmEL-Y3sMa7sX4g9b_Uuwp2vwjlcZmW9jhCZqvMUmR0Y8LDRw-1oLuJQhJbYO-ho6FZAsYp3W2S-2LCLDxCh--iFGvCiUeZOnzf5eRiVq4uoriPqMZsODXi11fU_fs3jfxF-AjeUam5SJ9lT6FWrOnuGELCKj2D_7GR-pLf3d-BZYEs
linkProvider	Unpaywall
linkToUnpaywall	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Zj9MwEB4tXQnYB86FDZeMtDyAlCZNnMOPEVAqUMsK0dXyFDmHtxFZp2oToeWH8HsZN05pQOKQyFMUjx3FHmu-ycx8BjgOcrxSrkKDgWfSJM9Mpgp1RYrGHuE5egiq3nk68ydz-vbMO9uDaVcLw3VW-LAraVAUFeg95paeSXOZCctxcbdbCFYcCwEHejRhgII8QXs6xPYrsO-reNMA9uezk-jTJuLJmKmMW8uf6qB2MEeHLdGp__EaPUzPTPVK33YQ6K-JlJpu9ACuNXLJL7_wstwxV-ObILsPbbNUPg-bOhmmX3_igPxvM3ELbmhgS6K2123Yy-UduDrVofu78M1BO0-6n_9kgjusJh8Wl_XiguzoCGkJlFBzyJumyHKCjxCjkvkabwWZVdI8LWp-UUjyjkRSxdQU9y95v1Ivl9iz4udNqbJ7CMqctLSxa6L-N5Noc0YJGasyh7JNAjyE-fj1x5cTUx8KYaaUhbWZ2MJ28hBxjpvhOvLQER7NHTtLHdsTIqChsBM_sRX1JLqSiFexOfRUfFdwPhq592AgK5kfAfEyKjLOGB0lIWU2DpW6rs-5oAhLM1sYYHU6EKeaMV0d3FHGbeTejbslifWUG_B822PZsoX8RvYYV_YvxJ52ehfjzlfhHC7zqlnHiEzVeYrMDg243-rhdjQXcShCS-wd9jR0K6BYxfstslhs2MVHiNB99EINeNYqc6_Pq-I0iqvVedw0MfWYTQMDXmx1_Y9f8-BfhB_CdaWam9RJ9ggG9arJHyMErJMnemN_B6OvXy8
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2021+European+Heart+Rhythm+Association+Practical+Guide+on+the+Use+of+Non-Vitamin+K+Antagonist+Oral+Anticoagulants+in+Patients+with+Atrial+Fibrillation&rft.jtitle=Europace+%28London%2C+England%29&rft.au=Steffel%2C+Jan&rft.au=Collins%2C+Ronan&rft.au=Antz%2C+Matthias&rft.au=Cornu%2C+Pieter&rft.date=2021-10-09&rft.eissn=1532-2092&rft.volume=23&rft.issue=10&rft.spage=1612&rft_id=info:doi/10.1093%2Feuropace%2Feuab065&rft_id=info%3Apmid%2F33895845&rft.externalDocID=33895845
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1099-5129&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1099-5129&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1099-5129&client=summon